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Abstract 
Abstract 
Human nuclear protein, hNP220, is a 1978-amino acid long nucleoplasmic protein 
with six types of domains: matrin 3 homologous region 1 (MHl), arginine-serine rich 
(RS), matrin 3 homologous region 2 (MH2), DNA-binding, acidic repeats (AR) and 
matrin 3 homologous region 3 (MH3). Among all domains, hNP220 shares three of 
them, namely MHl, MHl and MH3, with another human acidic nuclear protein 
known as matrin 3. hNP220 has long been speculated to be involved in packaging, 
transferring and processing of mRNA transcript. Recently, it has been proposed as a 
component of a complex involved in the regulation of myogenesis in human. 
hNP220 gene has as of today two splice variants reported, designated hNP220a and 
hNP2205. In this work, we identified the third alternatively spliced variant of 
hNP220, designated hNP220s, isolated from a human heart and testis cDNAs pool. 
This finding was corroborated by PGR, RT-PCR and Northern hybridization. 
Interestingly, a frameshift in hNP220s cDNA introduces a premature stop codon, 
resulting in the deletion of DNA-binding, AR and MH3 domains and the addition of 
a C-terminal leucine-rich basic leucine zipper-like motif (bZLM) that is found in 
hnRNP C as well. By using e/?z-fluorescence microscopy, hNP220s was shown to 
have a punctate subnuclear localization pattern, excluding nucleoli. Our studies also 
mapped the transcription start site of hNP220 gene by using RLM-RACE and 
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provided the first piece of evidence pointing to the potential protein-protein 
interaction between hNP2208 and microtubule-associated protein, RP/EB family, 
member 1 (MAPREl) by using CytoTrap® XR HeLa Cell cDNA Library screening. 
Interaction with MAPREl suggests hNP220 may be involved in the regulation of 
chromosome stability and oncogenesis in concert with or under the control of the 
Wnt signaling pathway. 
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摘 要 
摘要 
位於細胞核質、總長一千九百七十八個胺基酸的人類細胞核蛋白hNP220是由 
最少六種已知的結構域所組成’當中包括MH1�RS�MH2�DNA-binding�AR 
及M H 3 �在這六種結構域當中，M H 1 �M H 2及M H 3能在另一人類細胞核蛋 
白matrin 3中所找到。一直以來，hNP220被認爲與核糖核酸之組合、傳送和加 
工工序有關。最近，更有硏究指出hNP220可能在人類肌肉分化過程中起著調 
控作用。至今，hNP220基因共有兩個已知的分別剪接同等型，分別爲hNP220oc 
及hNP220So是次硏究中，在多聚酶鏈鎖反應、逆轉錄酶一多聚酶鏈鎖反應和 
北方雜合分析的協助下，我們於人類心臟和睾九的互補去氧核糖核酸基因庫中 
成功分離及鑑定出第三個h肥2 0分別剪接同等型 { h N P 2 m °與h N P 2 2 0 a及 
hNP220S不同，hNP220s因爲移碼突變而導致位於殘基末端的DNA-binding� 
AR及MH3結構域被刪除。同一時間，移碼突變亦爲hNP220s的殘基末端形成 
一個嶄新的bZLM結構域。根據螢光顯微鏡的分析，hNP22()s在除了細胞核質 
的細胞核中呈現出斑點狀的位置分佈。除此之外，是次硏究亦利用RLM-RACE 
方法確定出hNP220之轉錄起始點。在酵母雙雜交系統分析中，我們發現 
hNP220s有可能與另一個被命名爲MAPRE1的蛋白產生相互作用。由此，我們 
揣測hNP220有可能透過與MAPRE1之相互作用從而調控染色體之穩定性和影 
響癌生成之過程。 
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CHAPTER 1 Introduction 
1.1. Thesis synopsis 
This thesis is divided into four chapters. In Chapter 1, a concise background on the 
biological functions of hNP220 protein together with the principles of a couple of 
experimental methods employed in my work are to be given. In Chapter 2, materials 
and methods used in the identification of the third splice variant of hNP220 gene 
{hNP220£) and determination of the potential protein-protein interaction between 
hNP220s and MAPREl are to be detailed. In Chapter 3, experimental findings are to 
be presented. In Chapter 4, interpretation of the findings is to be given and potential 
roles of hNP220 in the regulation of chromosome stability and oncogenesis in 
concert with or under the control of the Wnt signaling pathway are to be discussed. 
1.2. hNP220 protein 
1.2.1. Domain organization 
hNP220 is a 1978-amino acid long DNA-binding nucleoplasmic protein with 
multiple domains and its cDNA was first isolated from libraries of HeLa and 
Namalwa cell lines based on its ability to recognize and bind to a cluster of cytidines, 
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possibly in the mitochondrial promoter region, in 1996 (Inagaki et al., 1996). In situ 
hybridization reveals that hNP220 gene has a chromosomal localization to 
2pl3.1-pl3.2 (Okumura et al., 1998). SDS electrophoresis indicates hNP220 has a 
molecular weight of about 250 kDa as opposed to being 220 kDa as predicted in 
silico. One plausible explanation for this anomalous migration is the high content of 
charged amino acids and their clustering. hNP220 has 6 types of domains identified 
so far. Domain organization and the function of each domain are depicted in 
Figure 1.1. Starting from the N-terminal, there is a matrin 3 homologous region 1 
(MHl) domain (residues 132-179) that is a 48-amino acid long region with no 
function identified as yet. Following MHl, there is an arginine/serine rich domain 
(RS) (residues 471-574) commonly found in pre-mRNA splicing factors. In the 
middle of hNP220, there is a matrin 3 homologous region 2 (MH2) domain (residues 
677-753, 906-981, 1010-1084) that is a 75-amino acid long region resembling the 
RNA recognition motifs (RRM) of hnRNPs I and L. MH2 is repeated 3 times in 
hNP220. Near the C-terminal, there contains a DNA-binding domain (residues 
1353-1477) that recognizes and binds to a cluster of cytidines (CCCCCG/C), and 
9 repeats of an acidic sequence LVTVDEVIEEEDL (residues 1541-1786) that carries 
transcriptional activation activity (internal unpublished data) in yeast Saccharomyces 
cerevisiae system. At the C-terminal, there is a matrin 3 homologous region 3 (MH3) 
domain (residues 1910-1978) which is a 60-amino acid long region with no known 
function as of today even though a Cys2-His2 zinc finger motif can be found there 
2 
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“/., 1996). Among all domains, hNP220 shares three of them, namely MHl, MH2 
and MH3, with another human acidic nuclear protein called matrin 3 (Belgrader et al., 
1991). 
In hNP220, the RS domain and RRM (or MH2) are structurally distinct from that of 
SR proteins in two aspects (Matsushima et al., 1996). Firstly, in SR proteins, the 
RRM is located at the N-terminal and the RS domain is at the C-terminal. Yet, in 
hNP220, the order of these two domains is reversed. Secondly, the RRM in hNP220 
contains no canonical RNPl and RNP2 sequences that are the identifying features of 
RRM (Swanson et al., 1987; Bandziulis et al., 1989; Kenan, 1991). Instead, the 
RRM of hNP220 is homologous to that of polypyrimidine tract-binding motif which 
can be found in splice factors such as U1-70K, U2AF, Drosophila splicing regulators 
transformer 2 (Tra2) and suppresser-of-white-apricot (Birney et al., 1993). In a 
nutshell, on the basis of domain organization, hNP220 is structurally distinct from 
that of SR proteins but resembling such splice factors as U2AF and Tra2 which 
activate 3'-splicing of specific genes with their polypyrimidine tract-binding motifs 
in response to tissue-specific, gene-specific or developmentally controlled signals 
(Matsushima et al., 1996). 
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Figure 1.1. Domain organization of full-length hNP220 protein. Speculated 
function is denoted by a S and empirically determined function is 
denoted by an E. Numbers in parentheses indicate amino acid residues 
of the corresponding domains. 
N-terminal Domain Function(s) 
一^一 … MH1 (132-179) Unknown 
m 
Arginine/serine rich [S] Speckled subnuclear 
� . d o m a i n (RS) localization 
f (471-574) 
MH2 / RNA recognition motif 
i (RRM) [S] RNA processing 
“ ( 6 7 7 - 7 5 3 , 9 0 6 - 9 8 1 ， 1 0 1 0 - 1 0 8 4 ) 
P 'A ‘ 
DNA-binding domain [E] Recognition and 
(1353-1477) binding to CCCCCG/C 
9 acidic repeats (ARs) [E] Transcriptional activation 
(1541-1786) 
MH3 f(x) unknown 
(1910-1978) 
Zinc finger motif 
C-terminal 
Not drawn in scale 
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1.2.2. Known splice variants 
NP220 forms a protein family having four members derived from alternative splicing 
of a common pre-mRNA. These forms are designated as a , p, y and 5. The a form, 
NP220a, represents the full-length NP220 protein. The p form, NP220p, has a 
34-amino acid sequence corresponding to residues 1850-1883 of hNP220a deleted. 
The y form, NP220y, has a 704-amino acid sequence corresponding to residues 
1146-1849 ofhNP220a deleted. The 5 form, NP2206, has both the deleted regions in 
3 and y forms absent, corresponding to residues 1146-1883 of hNP220a. RT-PCR 
showed that mouse has the transcripts for P, 丫 and 5 forms while human has the 
transcripts for a and 5 forms (Matsushima et al,, 1996; Matsushima et al., 1997). 
The two longer forms, NP220a and NP220p, have all the known domains mentioned 
in the previous section. In contrast, the two shorter forms, NP220y and NP2205, have 
their DNA-binding and acidic repeats domains missing (Figure 1.2). The shortest 
form of hNP220, hNP220§, has a remarkably high domain organization resemblance 
to matrin 3, suggesting that hNP2205 and matrin 3 may share very similar biological 
functions. As currently understood, there is no explanation for the possible roles and 
mutual functional linkage between the splice variants of hNP220. 
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Figure 1.2. Domain organization comparison among hNP220a, hNP2206, 
mNP220p, mNP220y and mNP2205. (A) Schematic diagram showing 
the domain structure of hNP220a, hNP2206, 
mNP220p, mNP220丫 and mNP2205. (B) Color codes used for the 
representation of NP220 domains. (C) Deleted amino acid region and 
domain(s) in NP220 isoforms. A 
N-terminal C-terminal 
hNP220a • • • • 
hNP2205 • • 丨 • 
mNP220(3 • • • • 
mNP220丫 • • 丨 • 
mNP220§ _ • • • 
Not drawn in scale 
B 
Matrin 3 homologous Matrin 3 homologous Acidic repeats 
region 1 (MH1) region 2 (MH2) (ARs) 
Arginine/serine rich DNA-bindinq Matrin 3 homologous 
(RS) region 3 (MH3) 
Zinc finger motif 
C 
Isoform Deleted residues (w.r.t. hNP220a) Deleted domain(s) 
a N/A N/A 
P 1850-1883 N/A 
y 1146-1849 DNA-binding, AR 
5 1146-1883 DNA-binding, AR 
(Matsushima et ai, 1996) 
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1.2.3. Subcellular localization 
hNP220 has an intranuclear subcellular localization as revealed by Western blot of 
subcellular fractions and indirect immunofluorescence microscopy. In interphase, 
hNP220 localizes in the LIS supernatant of nuclear matrix and gives a "speckled" 
pattern in the nucleus, excluding nucleoli. Starting from the onset of mitosis, the 
“speckled，，nucleoplasmic localization of hNP220 vanishes and it becomes diffusedly 
localized in the cytoplasm possibly as a consequence of reorganization of 
cytoskeleton and coiled bodies during mitosis (Inagaki et al., 1996). This localization 
behaviour in the course of mitosis is similar to those of spliceosomal snRNPs 
(Ferreira et al., 1994). 
1.2.4. Proposed roles in transcriptional activation and RNA processing 
Insights into the biological roles of hNP220 have been gained from prediction on the 
basis of its domain organization and subcellular localization pattern. Its speckled 
localization in interchromatin space, and possession of RS domain and RRM as for 
many components of spliceosomes such as non-small nuclear ribonucleoproteins 
(non-snRNPs), small nuclear ribonucleoproteins (snRNPs) and heterogeneous 
nuclear ribonucleoproteins (hnRNPs), suggests hNP220 may have significant 
importance for condensing and packaging of growing RNA transcripts, and for 
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alternative splicing of nascent pre-mRNA (Inagaki et al,, 1996). Since the hnRNP 
complexes contains more than 20 different proteins at the moment (for review sees 
Burd and Dreyfuss, 1994) and the list of proteins in the family of 
spliceosomes-associated SR protein is growing rapidly (Neugebauer et al., 1995), 
hNP220 may finally be classified as a member of hnRNPs or non-snRNPs with 
biological function in RNA processing. Apart from RRM, hNP220 carries a 
DNA-binding domain that recognizes and binds to a cluster of cytidines, possibly in 
the mitochondrial promoter region. Considering proteins that bind to both DNA and 
RNA such as TFIIIA, WT-1, TRA-1, bicoid, cj?。，STATl and TLS/FUS (for review 
sees Cassiday and Maher, 2002), hNP220 may behave similarly to such transcription 
factors as TFIIIA and WT-1 in the regulation of gene expression or to such splicing 
regulators as Wt-1 and TLS/FUS in the regulation of RNA processing. It is 
noteworthy that the Cys2-His2 zinc fingers required in the nucleic acid binding motifs 
of DNA/RNA binding proteins listed above are also found in hNP220 (one in MH3 
domain and another sandwiched between MHl and RS domains). Furthermore, 
unpublished internal data reveal that the 9 acidic repeats of hNP220 show 
transcriptional activation activity in vivo in yeast Saccharomyces cerevisiae. These 
information consolidates the speculation that hNP220 is likely to be a mammalian 
transcription factor. Moreover, it merits attention that matrin 3, an acidic nuclear 
protein that shares three domains, namely MHl, MH2 and MH3, with hNP220, has 
recently been reported to form a complex with inosine-specific RNA binding protein 
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p54nrb and polypyrimidine tract-binding protein-associated splicing factor (PSF), 
leading to the inosine-induced retention of promiscuously A-to-I hyper-editied RNAs 
to the nuclear matrix, while allowing selectively edited mRNAs to be exported 
(Zhang and Carmichael, 2001). The strikingly resembling domain organization 
between hNP220 and matrin 3 makes one wonder whether hNP220 has a role in the 
fate of RNA in the nucleus. Conclusively, with biological functions believed to be 
associated with RNA splicing, packaging and retention, and transcription control, 
hNP220 is highly likely to be a multifunctional protein that challenges the 
conventional “one protein-one function" paradigm. 
1.2.5. Interaction between C-terminal of hNP220 and FHL2 
C-terminal of hNP220 was found to interact with the second, third and forth LIM 
domains of four-and-a-half LIM protein 2 (FHL2) (Ng et al., 2002). FHL2 is a 
transcriptional coactivator with tumor suppressor potential (Genini et al., 1997) and 
with remarkably high level of mRNA expression in human heart and skeletal muscle 
tissues (Miiller et al., 2000). FHL2 has long been shown to have protein-protein 
interaction with a multitude of proteins, including hCDC47 (Chan et al., 2000), 
androgen receptor (Miiller et al., 2000), alpha and beta integrin chains (Wixler et al., 
2000), FHL3 (Li et al., 2001), hNP220 (Ng et al., 2002), insulin-like growth 
factor-binding protein 5 (IGFBP-5) (Amaar et al., 2002), promyelocytic leukemia 
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zinc finger protein (McLoughlin et al., 2002) and p-catenin (Martin et al., 2002; Wei 
et al., 2003). FHL2 may, therefore, have a dual function: interacting with 
cytoplasmic proteins such as integrin chains and with nuclear proteins such as 
androgen receptor. This duality is also reflected by the subcellular localization of 
FHL2 observed in nucleus, cytoplasm and focal adhesion (Li et al., 2001; Scholl et 
al., 2000; Wixler et al., 2000), and the translocation of FHL2 from cytoplasm into 
nucleus in the presence of hNP220 (Ng et al., 2002). In fact, it has been reported that 
RRM2 interacts with FHL2 in which the zinc-finger or LIM domains may contribute 
to the nucleoplasmic "speckled" localization of proteins having RRM2, including 
polypyrimidine tract binding protein-associated splice factor (PSF) (Dye, 2001). 
These findings suggest that FHL2 may mediate cellular signals between cytoplasm 
and nucleus and behave as a molecular adapter in complex formation (Dawid et al., 
1998). Taken into consideration the interaction between C-terminal of hNP220 and 
FHL2, it is proposed that hNP220, believed to be a mammalian factor regulating 
gene-specific RNA splicing in tissue-specific, gene-specific or developmentally 
controlled manner (Matsushima et al., 1996), recruits the heart- and skeletal 
muscle-specific FHL2 and forms a multifunctional complex. This complex may, in 
turn, bind to DNA, triggering temporally controlled transcription of heart- or 
muscle-specific genes in the course of heart development (Ng et al., 2002), and 
regulate RNA splicing of the mRNAs synthesized, resulting in transcriptional and 
post-transcriptional regulation of myogenesis. Known and inferred biological 
functions of hNP220 are depicted in Figure 1.3. 
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Figure 1.3. Known and inferred biological functions of hNP220. 
RNA condensing, packaging, splicing 
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1.3. Hypothesis 
The protein-protein interaction of the C-terminal of hNP220 and FHL2 gives us 
insights into the possible participation of hNP220 in tissue-specific control of cell 
development. In effect, it has been proposed that hNP220, believed to be a 
mammalian factor regulating RNA splicing in a tissue-specific, gene-specific or 
developmentally controlled manner (Matsushima et al., 1996), recruits the heart- and 
skeletal muscle-specific FHL2 and forms a multifunctional complex. This complex, 
in turn, may bind to target DNA, triggering temporally controlled transcription of 
heart- or muscle-specific genes in the course of heart development (Ng et al., 2002), 
and may regulate RNA splicing of the mRNAs synthesized, resulting in 
transcriptional and post-transcriptional regulation of myogenesis. Considering the 
dual DNA/RNA binding properties of hNP220, we put forward further that hNP220 
may be a mammalian transcription factor in the regulation of gene expression in 
myogenesis under the control of transcriptional coactivator FHL2. In fact, FHL2 has 
recently been shown as a transcriptional coactivator that transmits Rho signals from 
the cell membrane into the nucleus (Miiller et al., 2002). The follow-up question is: 
do hNP220 and FHL2 define a novel signaling pathway or are they solely 
intermediate relay components of any known signaling cascades? To attack this 
question, CytoTrap® two-hybrid system was preferentially chosen to screen for any 
novel and potential protein interaction partners of hNP220 in an attempt to extend the 
current hNP220-FHL2 protein interaction map and/or to link hNP220 to 
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component(s) of other signaling pathway(s). Intriguingly, unexpected PGR result 
during the cloning procedures of hNP220 gene into CytoTrap® two-hybrid bait 
vector pSos leads to the identification of the third splice variant of hNP220 gene, 
hNP220s, by serendipity. 
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1.4. Principles of key methods 
1.4.1. RLM-RACE 
Determination and analysis of the 5' sequence of mRNA is of great importance in 
gene characterization not only because it ensures that the cloned cDNA is of full-size, 
but also it is a prerequisite for the determination of the exact site of transcription and 
translation initiation. It is, therefore, useful for the promoter and enhancer mapping 
that are necessary for other studies on gene expression and regulation. In this study, 
RNA ligase-mediated rapid amplification of cDNA end, abbreviated RLM-RACE, 
was employed due to its accuracy and simplicity. The template, Cap Site cDNA™ dT 
(NIPPON GENE, Japan), was manufactured commercially by first decapping 
mRNAs using tobacco nucleotide acid pyrophosphatase (TAP) (Shinshi et al., 1976), 
followed by ligation of the 3'-end of specific 38mer oligoribonucleotides to the 
5'-end of the decapped mRNAs in the presence of RNA ligase (Fumichi and Shatkin, 
1989). These oligo-38mer capped mRNAs were then reversely transcribed to 
oligo-38mer cDNAs using oligo dT primers. The product, Cap Site C D N A ' ^ ^ dT, is a 
cDNA library containing the precise and non-degraded sequences around the 
5' capping site of source mRNAs. 
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1.4.2. CytoTrap® two-hybrid system 
Protein-protein interaction is the driving force behind all cellular biochemical 
processes and the mapping of all protein-protein interactions is, therefore, pivotal to 
our better understanding of how life works. Traditionally, protein-protein interaction 
has been studied using such techniques as co-immunoprecipitation, crosslinking and 
co-fractionation by chromatography (Fields and Song, 1989). Recently, another 
research group has developed ways to unravel protein-protein interaction using 
Antibody Array system (Wang et al., 2000). However, these systems share two 
drawbacks: low throughput and tedious procedures. Such limitations hold up their 
wider adoption in large-scale screening for protein-protein interaction. This is where 
yeast two-hybrid system brings in. The first use of the yeast two-hybrid system is 
attributed to Fields and Songs (Fields and Song, 1989). Since then, yeast two-hybrid 
system has developed into one of the most popular and powerful tools in molecular 
biology in the analysis of protein-protein interaction despite the fact that the concept 
behind yeast two-hybrid system is elegantly simple. Yeast two-hybrid system permits 
brute force protein-protein interaction screening of our protein of interest (bait) 
against the entire proteome to be completed within weeks. Yeast two-hybrid system 
has also evolved further with its scope of applications expanded to areas involving 
the studies of protein-DNA and protein-RNA interactions (yeast one-hybrid system). 
Stratagene's CytoTrap® two-hybrid system is a novel derivative of the original yeast 
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two-hybrid system invented by Fields and Song. CytoTrap® two-hybrid system is 
based on generating two fusion proteins, hSos-bait (pSos-bait) and myristylation 
signal-target (pMyr-target), whose interaction in the yeast cytoplasm activates the 
Ras-signaling pathway, allowing temperature-sensitive mutant yeast Saccharomyces 
cerevisiae strain cdc25H to grow at an elevated temperature of 37°C. A schematic 
diagram of CytoTrap® two-hybrid system is shown in Figure 1.4. Briefly, CytoTrap® 
two-hybrid system uses the temperature-sensitive mutant of yeast Saccharomyces 
cerevisiae strain cdc25H which contains a point mutation at residue 1328 of the 
CDC25 gene (Petitjean et al., 1990). CDC25 gene is the yeast homologue of the 
human Sos (hSos) gene, encoding a guanyl nucleotide exchange factor that binds and 
activates Ras protein, triggering the Ras=signaling transduction pathway. The cdc25 
mutation present in the cdc25H strain prevents growth at 37°C, while allowing for 
normal growth at 25�C. ytoTrap® two-hybrid system makes use of the ability of the 
hSos protein to complement the cdc25 defect and to activate the yeast Ras-signaling 
transduction pathway. Target protein from the cDNA library being screened is 
anchored to the yeast cell membrane by myristylation signal. Interaction between the 
target and the bait proteins brings the hSos protein in close proximity to the Ras 
protein on the yeast cell membrane. This way, the hSos protein complements the 
cdc25 defect and activates the Ras protein by promoting GDP/GTP exchange. 
Activated Ras protein triggers downstream signaling cascade, resulting in growth of 
mutant yeast cdc25H at 37�C (Stratagene's CytoTrap® XR Library Construction Kit 
Instruction Manual). 
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Figure 1.4. CytoTrap® two-hybrid system. hSos-bait and myristylation 
signal-target fusion constructs were used. Protein-protein interaction 
between the bait protein and the target protein brings the hSos protein 
in close proximity to Ras protein localized on the yeast cell membrane 
surface. Ras protein becomes activated, triggering downstream 
Ras-signaling pathway that makes the temperature-sensitive mutant 
yeast cdc25H able to grow at an elevated temperature of 37°C. 
Not drawn in scale 
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CHAPTER 2 Materials and Methods 
2.1. Cloning protocol 
Unless otherwise specified, all cloning procedures were performed as described 
below. 
2.1.1. Amplification of DNA fragment 
Each PGR reaction mix contained 1 i^l DNA template, 0.5 |iM forward primer, 
0.5 |iM reverse primer, IX Advantage® 2 polymerase mix (BD Biosciences Clontech, 
CA), 0.5 unit Pfu DNA polymerase (Stratagene, CA), 200 fiM each dNTP, and 
IX Advantage® 2 PGR buffer in a total volume of 50 The thermal cycling profile 
was as follows: denaturation at 95°C for 5 min, followed by 35 cycles of 
denaturation at 9 4 � C for 36 sec, annealing at 55-68°C for 36 sec and primer 
extension at 6 8 � C for 1-7 min (1 min/kb of expected PGR product size). A final 
extension was given at 68°C for 10 min. Thermal cycling was carried out in a 
PTC-100 or PTC-200 programmable thermal cycler (MJ Research, Inc., CA). 
Molecular grade mineral oil was added in case of using thermal cycler without 
heated-lid. Following PGR, 5 |il PGR product was then electrophoresed, and 
visualized under ultraviolet light on a 0.8-2.0% TAE agarose gel stained with 
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ethidium bromide. Control(s) was/were performed in parallel. 
2.1.2. Purification of PGR product 
Purification of PGR product was carried out using GENECLEAN® III Kit 
(BIO 101, CA) as per manual. Briefly, PGR product was electrophoresed on a 
0.8-2.0% TAE agarose gel. The required band was excised and melted in 1 mL 
6M sodium iodide solution (kit component) by incubating the mixture at 55°C with 
occasional shaking until the gel slice was completely melted. Five 
EZ-GLASSMILK® (kit component) was added to allow binding of the DNA to the 
silica matrix. The suspension was incubated at room temperature for 10 min with 
continuous and gentle shaking. After incubation, the suspension was centrifuged at 
13,000 rpm for several seconds. The supernatant was discarded and the pellet was 
resuspended and washed once in 400 \A NEW wash solution (kit component). The 
suspension was centrifuged at 13,000 rpm for several seconds. The supernatant was 
aspirated and discarded, and the pellet was dried under air. Elution of DNA from 
EZ-GLASSMILK® was completed by resuspending the pellet in 10 fJ nanopure H2O, 
followed by centrifugation at 13,000 rpm for several seconds and aspiration of the 
supernatant containing the required and purified DNA. 
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2.1.3. Restriction endonuclease digestion 
Cloning vector and purified PGR product were subject to restriction endonuclease(s) 
digestion. Each 20 )al-reaction mix was composed of 10 units required restriction 
endonuclease(s), approximately 1 i^g cloning vector or purified PGR product, and 
One-Phor-All Buffer PLUS (Amersham Biosciences, NJ) at the required 
concentration. The reaction mix was incubated at the working temperature of 
endonuclease overnight and thereafter restriction endonuclease(s) was/were 
inactivated by heat killing at 85°C for 20 min. Control(s) was/were performed in 
parallel. 
2.1.4. Dephosphorylation of cloning vector 5'-termini 
One unit CIAP enzyme (Fermentas, MD) was added directly to the inactivated 
digestion reaction mix and the mixture was incubated at 37°C for 1 hr. Inactivation of 
CIAP was done by heating the reaction mix at 85°C for 20 min. 
2.1.5. Insert/vector ligation 
Digested cloning vector and purified PGR product with compatible ends were ligated 
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in a molar ratio 1:3 in a 30 ^1-reaction mix containing 1 unit (1 of a 1:400 dilution) 
of T4 DNA ligase (New England Biolabs, Inc., MA) and IX T4 DNA Ligase 
Reaction Buffer. The ligation reaction mix was incubated at 16°C overnight. 
Control(s) was/were performed in parallel. 
2.1.6. Preparation of chemically competent bacterial cells (E, coli strain DH5a) 
Preparation of chemically competent bacterial cells was based on Hanahan method 
(Hanahan, 1983). On day 1, a single colony of E. coli strain DH5a was inoculated 
with 10 mL LB medium and the culture was incubated at 3TC overnight (16-20 hr) 
with shaking at 250 rpm. On day 2, 7.5 mL overnight culture was sub-cultured into 
250 mL LB medium and further incubated at 37°C for about 2 hr with shaking at 
250 rpm until its absorbance at wavelength 600 nm reached 0.3. Bacterial cells were 
harvested by centrifugation at 3,500 rpm at 4°C for 10 min. The supernatant was 
decanted and the cell pellet was resuspended in 83 mL (one-third volume of the 
original culture volume) RFl (100 mM RbCl, 50 mM MnClz^HsO, 30 mM 
potassium acetate, 10 mM CaCl2 2H20 and 15% glycerol [w/v], pH 5.8). The 
suspension was incubated on ice for another 15 min and the cells were harvested by 
centrifugation at 3,500 rpm at 4°C for 10 min. The supernatant was discarded and the 
cell pellet was resuspended in 20 mL (1/12.5 volume of the original culture volume) 
RF2 (10 mM MOPS, 10 mM RbCl, 75 mM CaC^^HiO and 15% glycerol [w/v], 
21 
Materials and Methods 
pH 6.8). The suspension was incubated on ice for 15 min and then aliquoted into 
200 |il fraction. Aliquoted chemically competent bacterial cells were quickly frozen 
in liquid nitrogen and stored at -80°C. RFl and RF2 were filter-sterilized before use. 
2.1.7. Transformation of ligation product into chemically competent bacterial 
cells 
Frozen chemically competent bacterial cells were thawed on ice for 30 min. Ligation 
reaction mix was added to the thawed competent bacterial cells and the 
transformation reaction mix was incubated on ice for another 30 min, followed by a 
heat shock at 42°C for 90 sec and a quick chilling on ice for 3 min. 800 LB 
medium was added to each transformation reaction mix which was then incubated at 
37°C for 1 hr with shaking at 250 rpm. The transformation reaction mix was then 
centrifuged at 13,000 rpm for several seconds and the supernatant was decanted. The 
cell pellet was resuspended in the residual LB medium and the suspension was 
completely plated onto LB agar plate containing the appropriate selection antibiotic. 
2.1.8. Small-scale preparation of bacterial plasmid DNA 
Extraction of bacterial plasmid DNA was accomplished using the Rapid Plasmid 
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Miniprep System (Marligen Biosciences, Inc., MD) as per manual. Briefly, a single 
well-defined bacterial colony was inoculated with 1 mL LB medium containing the 
appropriate selection antibiotic. The culture was allowed to grow at 37°C overnight 
with shaking at 250 rpm. Before cell harvesting, TE Buffer (TE) was pre-warmed at 
70°C. Cells were harvested by centrifugation at 13,000 rpm for lOmin. The 
supernatant was discarded and the cell pellet was resuspended in 250 Cell 
Suspension Buffer (Gl) by vortexing. 250 fil Cell Lysis Solution (G2) was added. 
The contents were mixed by inverting the tube five times and incubated at room 
temperature for precisely 5 min. 350 \i\ Neutralization Buffer (M3) was added and 
mixed immediately by inverting the tube five times. The suspension was then 
centrifuged at 13,000 rpm for 10 min. The supernatant was loaded into a spin 
cartridge that was placed in a 2-mL wash tube. The composite was centrifuged at 
13’000 rpm for 1 min. The flow-through was discarded. 700 Wash Buffer (G4) 
was added to the spin cartridge and the composite was centrifuged at 13,000 rpm for 
1 min. The flow-through was discarded and the composite was re-centrifuged again 
at 13,000 rpm for 1 min to remove residual wash buffer. The spin cartridge was 
placed into a 1.5-mL recovery tube. 75 i^l pre-warmed TE Buffer was added directly 
to the center of the spin cartridge and the composite was incubated at room 
temperature for 1 min. Purified plasmid DNA was eluted and collected by 
centrifuging the composite at 13,000 rpm for 1 min. 
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2.1.9. Screening for recombinant clone 
Purified bacterial plasmid DNA was screened for the desired insert by digesting the 
plasmid with the corresponding restriction endonuclease(s) used in cloning. Each 
10 |al-digestion reaction mix was composed of 10 units corresponding restriction 
endonuclease(s) used in cloning and One-Phor-All Buffer PLUS (Amersham 
Biosciences, NJ) at the required concentration. Purified bacterial plasmid DNA was 
added to make the final total volume to 10 The digestion reaction mix was 
incubated at the working temperature of endonuclease for 1 hr. Digested plasmid was 
visualized and analyzed under ultraviolet light on a 0.8-2.0% TAE agarose gel 
stained with ethidium bromide. 
2.1.10. Dideoxy DNA sequencing 
Purified bacterial plasmid DNA containing the desired insert of expected size was 
checked for reading frame, and vector and insert identities by using dideoxy DNA 
sequencing with Thermo Sequenase™ Cycle Sequencing Kit (USB, OH) as per 
manual. IRDye700- and IRDyeSOO- fluorescently labeled sequencing primers were 
used where appropriate. The thermal cycling profile was as follows: denaturation at 
96°C for 5 min, followed by 40 cycles of denaturation at 95°C for 30 sec, annealing 
at 50°C for 30 sec and primer extension at 72°C for 2 min. A final extension was 
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given at 72°C for 10 min. Standard slab gel electrophoresis was performed using a 
LI-COR 4200 DNA Sequencer (LI-COR, NE). 
2.1.11. Midi-scale preparation of recombinant plasmid DNA 
After sequence verification, midi-scale preparation of the purified recombinant 
bacterial plasmid DNA was performed using HiSpeed™ Plasmid Midi Kit (QIAGEN 
Inc., CA) as per manual. Briefly, the purified recombinant plasmid DNA was 
transformed into chemically competent E. coli DH5a as detailed previously. A single 
colony was picked and inoculated with 100 mL LB medium. The culture was 
allowed to grow at 3 7 � C for 12-16 hr with shaking at 250 rpm. The bacterial cells 
were harvested by centrifugation at 6000 x g for 15 min at 4 � C . The supernatant was 
discarded and the pellet was resuspended in 6 mL Buffer PI by vigorous vortexing. 
Six mL Buffer P2 was added and mixed gently by inverting the plasmid-containing 
vessel 5 times. The mixture was incubated at room temperature for exactly 5 min. 
During the incubation, a cap was screwed onto the outlet nozzle of a QIAfilter™ 
Midi Cartridge. After the 5-min incubation, 6 mL Buffer P3 was added to the lysate 
and the contents were mixed immediately but gently by inverting the vessel 5 times. 
The neutralized lysate was then poured into the barrel of the QIAf i l t e r™ Midi 
Cartridge. The QIAfilter™ Midi Cartridge was incubated at room temperature for 
10 min. During the incubation, a HiSpeed™ Midi Tip was equilibrated by applying 
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4 mL Buffer QBT. After the 10-min incubation, the cap from the QIAfilter™ outlet 
nozzle was removed and the cell lysate was filtered into the previously equilibrated 
HiSpeed™ Midi Tip by inserting and pressing the plunger into the QIAfilter^^ Midi 
Cartridge. The cleared lysate was allowed to enter the resin by gravity flow. The 
HiSpeed™ Midi Tip was washed with 20 mL Buffer QC and the bound DNA was 
eluted with 5 mL Buffer QF. 3.5 mL room-temperature isopropanol was added to 
precipitate DNA and the contents were mixed. The mixture was incubated at room 
temperature for 5 min. During the incubation, the plunger from a 20 mL syringe was 
removed and a QIAprecipitator™ Midi Module was attached onto the outlet nozzle. 
After the 5-min incubation, eluate/isopropanol mixture was transferred into the 
20 mL syringe. The mixture was filtered by inserting the plunger into the 20 mL 
syringe. The QIAprecipitator™ was removed from the 20 mL syringe and the 
plunger was pulled out. The QIAprecipitator™ was re-attached to the 20 mL syringe. 
The bound DNA was dried by inserting the plunger again and pressing air through 
the QIAprecipitator™. The plunger was removed from a new 5 mL syringe and the 
QIAprecipitatofTM transferred from the 20 mL syringe to the new 5 mL syringe. 
500 \i\ Buffer TE was added to the 5 mL syringe and the plunger was inserted and 
pressed to elute the purified recombinant bacterial plasmid DNA into a 1.5 mL 
collection tube. 
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2.2. Determination of the transcription start site (TSS) of hNP220 gene 
2.2.1. RNA ligase-mediated rapid amplification of cDNA 5'-end 
(S'-RLM-RACE) 
Human testis CapSite c D N A ' ^ ^ dT (NIPPON GENE, Japan) was used as template in 
5'-RLM-RACE. CapSite cDNA^^ dT is a cDNA library containing the precise and 
non-degraded sequences around the 5' capping site of source mRNAs. 
5'-RLM-RACE was performed as per manual. Briefly, the purchased template was 
first diluted 10-fold in nanopure water. Nested PGR was carried out. In the first 
round, the PGR reaction mix was composed of 1 diluted template, 0.5 |iM forward 
primer IRDT (kit component), 0.5 fiM gene-specific reverse primer TSS-334-R 
(Table 2.1), 2 units Pfu DNA polymerase (Stratagene, CA), 200 pM each dNTP, and 
IX PGR buffer. In the second round, the PGR reaction mix was composed of 1 \il 
first round PGR product, 0.5 |aM forward primer 2RDT (kit component), 0.5 juM 
gene-specific reverse primer TSS-240-R (Table 2.1), 2 units Pfu DNA polymerase, 
200 jiiM each dNTP, and IX PGR buffer. The thermal cycling profile was as follows: 
denaturation at 95°C for 5 min, followed by 35 cycles of denaturation at 94°C for 
36 sec, annealing at 59°C for 36 sec and primer extension at 72°C for 1 min. A final 
extension was given at 72°C for 10 min. The PGR product was then gel-purified 
using GENECLEAN® III Kit (BIOlOl, CA), and cloned into 5'm^I-digested vector 
pEGFP-Cl (BD Biosciences Clontech, CA). Four recombinant clones were selected 
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with their plasmids extracted, purified and sequenced using LI-COR 4200 DNA 
Sequencer (LI-COR, NE). 
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2.3. Isolation and identification of the third splice variant of hNP220 
(hNP220s) 
2.3.1. PCR from human heart/testis cDNAs pool 
PCR of hNP220 was performed using a pool of Human Heart Marathon-Ready^^ 
and Human Testis Marathon-Ready丁M C D N A S (BD Biosciences Clontech, C A ) as 
template. The flanking primers used were NP220-F-Sos and NP220-R-Sos 
(Table 2.1). Annealing temperature used was 68°C. Following PCR, all amplified 
bands were cloned into CytoTrap® two-hybrid bait vector pSos (Stratagene, CA) and 
completely sequenced. 
2.3.2. RT-PCR 
Human fetal and adult Multiple Tissue cDNA (MTC^^) Panels were purchased from 
Clontech (BD Biosciences Clontech, CA). Pre-normalized MTC'^^ Panels, composed 
of first-strand cDNAs generated from poly A+ RNA isolated from different human 
tissues, were used as PCR templates in an attempt to amplify fragments of both 
NP220a and NP220S cDNAs by using two primer pairs: MTC-3480-F / 
MTC-4999-R and MTC-4981-F / MTC-6000-R (Table 2.1) in two independent 
experiments. Taq DNA polymerase was added and the thermal cycling profile was as 
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follows: denaturation at 95°C for 5 min, followed by 35 cycles of denaturation at 
94°C for 36 sec, annealing at 56°C for 36 sec and primer extension at 72°C for 2 min. 
A final extension was given at 72°C for 10 min. PGR products were then 
electrophoresed, and visualized on 2% TAE agarose gels post-stained by IX SYBR® 
Green I nucleic acid gel stain (Molecular Probes, OR) for 30 min. 
2.3.3. Northern hybridization 
12-Lane Multiple Tissue Northern (MTN®) Blot was purchased from Clontech (BD 
Biosciences Clontech, CA). Northern hybridization analysis was performed as per 
manual. Briefly, the pre-normalized MTN® Blot, containing approximately 1 mg of 
poly A^ RNA per lane from specific human tissues, was first prehybridized in 
ExpressHyb™ Hybridization Solution at 68°C for 30 min, followed by hybridization 
at 68�C for 1 hr with a radioactively [a-^^P]-labeled cDNA probe (301bp) designed 
from the coding region of hNP220 (nt. 528-828, GenBank accession no. 
NM 014497.2). PGR primers used for cDNA probe synthesis are listed in Table 2.1. 
After hybridization, the MTN® Blot was washed stepwise with 2X SSC containing 
p/o SDS, IX SSC containing 0.5% SDS and 0.5X SSC containing 0.25% SDS. 
Autoradiography was performed by exposing the labeled blot to BioMax MR film 
(Kodak) in the presence of an intensifying screen at -80°C for 3 days. 
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2.4. Human tissue distribution of hNP220 
2.4.1. RT-PCR 
Identical to Section 2.4.2 on page 29. 
2.4.2. Northern hybridization 
Identical to Section 2.4.3 on page 30. 
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2.5. Visualization of the subcellular localization patterns of GFP-tagged 
hNP220s in HepG2 cell line 
2.5.1. Cloning of hNP220a and hNP220s into vector pEGFP-Cl 
PGR of hNP220a and hNP220s were performed using a pool of Human Heart 
Marathon-Ready™ and Human Testis Marathon-Ready™ cDNAs (BD Biosciences 
Clontech, CA) as template. The flanking primers used were NP220-F-GFP and 
NP220-R-GFP (Table 2.1). Annealing temperature used was 68�C. Following PGR, 
the amplified bands corresponding to hNP220a and hNP2206v^QVQ cloned into vector 
pEGFP-Cl (BD Biosciences Clontech, CA) and completely sequenced. The two GFP 
fusion constructs were designated pEGFP-Cl-hNP220a and pEGFP-Cl-hNP220s. 
2.5.2. Transfection of GFP fusion constructs into HepG2 cell line 
HepG2 cell line was purchased from ATCC, cultured in RPMI-1640 medium (Gibco, 
CA) supplemented with 10% (v/v) fetal bovine serum and 1% 
penicillin-streptomycin, and maintained at 37°C in 5% CO2. Transfections were 
performed using the Lipofectamine Plus™ Reagent package (Invitrogen, CA) as per 
manual. Cells were harvested for fixation on slides and DAPI (Molecular Probes, OR) 
staining was done 16 hr after transfection. 
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2.5.3. £/7/-fluorescence microscopy 
Subcellular localization of GFP-tagged hNP220a and hNP220s were observed by 
^/^/-fluorescence microscopy. For GFP detection, fixed HepG2 cells were excited by 
a 488 nm laser and emitted light was filtered by a 530DF30 filter (Omega Optical, 
NE). For DAPI detection, fixed HepG2 cells were excited by a 365 nm laser and 
emitted light was filtered by a 450DF65 filter (Omega Optical, NE). Images were 
captured by a cooled Sensys CCD camera (Photometric, AZ) and pseudo-colored 
using IPLab Spectrum 3.1a for Macintosh (Scanalytics, VA). 
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2.6. Identification of the protein-protein interaction between hNP220s and 
MAPREl 
2.6.1. CytoTrap® XR HeLa Cell cDNA Library screening 
2.6.1.1. Cloning of hNP220s into yeast two-hybrid bait vector pSos 
PGR of hNP220s was performed using a pool of Human Heart Marathon-Ready^^ 
and Human Testis Marathon-Ready^^ cDNAs (BD Biosciences Clontech, CA) as 
template. The flanking primers used were NP220-F-Sos and NP220-R-Sos 
(Table 2.1). Annealing temperature used was 68°C. Following PGR, the amplified 
band corresponding to hNP220s was cloned into CytoTrap® two-hybrid bait vector 
pSos (Stratagene, CA) and completely sequenced. This bait fusion construct was 
designated pSos-hNP220s. 
2.6.1.2.Preparatioii of cdc25Ha & cdc25Ha yeast competent cells 
cdc25Ha and cdc25Ha yeast competent cells were prepared freshly as per manual. 
Briefly, 4-5 cdc25Ha and cdc25Ha colonies no more than 6 days old were picked 
from the freshly plated plates and inoculated with 50 mL YPAD medium (1% yeast 
extract, 2% Bacto® peptone, 2% dextrose and 2 mg adenine sulfate) separately. The 
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yeast cultures were incubated at exactly 24.5°C with shaking at 250 rpm until the 
absorbance of the yeast cultures at wavelength 600nm (OD600) exceeded 1.0 (about 
14-16 hr). The overnight yeast cultures were then diluted to a total volume of 300 mL 
YPAD medium such that ODeoo of the diluted yeast cultures dropped to 0.2. The 
diluted yeast cultures were further incubated at exactly 24.5°C with shaking at 
250 rpm until the OD600 exceeded 0.7 (about 3 hr). 75 |il of each of the diluted yeast 
cultures were plated on YPAD agar plates and incubated at 37°C for 4-6 days, 
checking for temperature-sensitive yeast revertants. The remaining volume of the 
diluted yeast cultures were harvested by centrifugation at 1000 x g for 5 min at room 
temperature (22-25°C). The supernatant was discarded and the yeast cell pellets were 
washed by resuspending in 50 mL nanopure water. The suspensions were centrifuged 
at 1000 X g for 10 min at room temperature. The supernatant was discarded and the 
yeast cell pellets were resuspended in 50 mL LiSORB solution (100 mM LiOAc, 
10 mM Tris-HCl at pH 8.0, 1 mM EDTA and 1 M sorbitol, pH 8.0). The suspensions 
were incubated at room temperature for 30 min. During the incubation, for each of 
the yeast cultures, 400 [A of 20 mg/ml sheared salmon sperm DNA was boiled for 
10 min, followed by the addition of 600 |al LiSORB solution. The contents were 
mixed and cooled down to room temperature. After the 30-min incubation, the yeast 
suspensions were pelleted by centrifugation at 1000 x g for 5 min at room 
temperature. The supernatant was discarded and the yeast cells were resuspended in 
300 |il LiSORB solution. 600 ]il of the prepared salmon sperm DNA was added into 
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each yeast suspension and the contents were mixed thoroughly but gently by 
pipetting. 5.4 mL PEG/LiOAc solution (10 mM Tris-HCl at pH 8.0, 1 mM EDTA at 
pH 8.0, 100 mM LiOAc at pH 7.5 and 40% PEG 3350 [w/v]) and 530 i^l DMSO 
were added to each yeast suspension. cdc25Ha and cdc25Ha yeast competent cells 
were ready for immediate use. 
2.6.1.3. Autonomous activation study of bait fusion construct pSos-hNP2208 
The bait fusion construct pSos-hNP220s was checked for the absence of interaction 
with the myristylation signal in the absence of an interaction partner by 
cotransforming pSos-hNP2208 into cdc25Ha yeast competent cells with the prey 
vector pMyr. The cotransformation was performed as per manual that resembled the 
protocol outlined in the section below. 
2.6.1.4. Cotransformation of pSos-hNP220s and CytoTrap® XR HeLa Cell 
cDNA Library 
40 |ig of pSos-hNP220s bait fusion construct, 40 昭 CytoTrap® XR HeLa Cell cDNA 
Library in pMyr and 200 |il 1.4 M p-mercaptoethanol were added to 10 mL freshly 
prepared cdc25Ha yeast competent cells. The contents were mixed gently by 
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inverting the vessel 5 times. The mixture was then aliquoted evenly into 20 separate 
1.5 mL tubes. As a negative control, 2 |ig pSos vector, 2 fig CytoTrap® XR HeLa Cell 
cDNA Library in pMyr and 10 |LI1 1.4 M P-mercaptoethanol were added to 500 I^L 
freshly prepared cdc25Ha yeast competent cells in a separate 1.5 mL tube. All of the 
21 tubes were incubated at room temperature (22-25°C) for 30 min with occasional 
mixing. The transformation mixtures were then heat shocked at 42°C for 20 min, 
followed by a quick chill on ice for 3 min. The transformed yeast cells were 
harvested by centrifugation at 13,000 rpm for 30 sec. The supernatant was discarded 
and the cell pellets were resuspended in 0.5 mL IM sorbitol solution. Each 
transformation mixture was plated on a 150-mm SD/glucose (-UL) agar plate. The 
plates were incubated at 24.5°C for 48 hr. All the SD/glucose (-UL) agar plates were 
replica plated onto SD/galactose (-UL) agar plates. The SD/galactose (-UL) plates 
were incubated at 37°C for 10 days. Colonies (interactor candidates) were patched 
onto SD/glucose (-UL) agar plate and were incubated at 24.5°C for 48 hr, repressing 
GALl promoter-driven expression from the pMyr library prior to interaction tests. 
Cells from the SD/glucose (-UL) agar plate were patched onto two fresh SD/glucose 
(-UL) agar plates and one SD/galactose (-UL) agar plate. One of the SD/glucose 
(-UL) agar plate and the SD/galactose (-UL) agar plate were incubated at 37°C, and 
the other SD/glucose (-UL) agar plate was incubated at 24.5°C as a re-patching 
source plate. Growth was scored and analyzed after incubation for 48 hr. Patches that 
showed growth at 37°C on SD/galactose (-UL) agar plate, but not at 37°C on 
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SD/glucose (-UL) agar plate were subject to re-patching from the re-patching source 
plate onto another set of one SD/glucose (-UL) and one SD/galactose (-UL) agar 
plates, with both plates incubated at 37°C for 48 hr. Patches that showed growth at 
37°C on SD/galactose (-UL) agar plate, but not at 3 7 � C on SD/glucose (-UL) agar 
plate were identified as putative interaction partners of hNP220s. 
2.6.1.5. Verification of interaction by yeast mating 
2.6.1.5.1. Generation of yeast plasmid segregant for mating 
Colonies of putative interaction partners of hNP2208 obtained from CytoTrap® XR 
HeLa Cell cDNA Library screening were incubated with 3 mL SD/glucose (-U) 
liquid medium for 2 days at 24.5°C with shaking at 250 rpm. 300 i^l yeast cultures 
were plated on SD/glucose (-U) agar plates. The plates were incubated at 24.5°C 
until colonies appeared. Colonies were transferred to SD/glucose (-U) and 
SD/glucose (-L) agar plates. The plates were incubated at 24.5°C for 2-4 days. 
Colonies that showed growth on SD/glucose (-U) agar plate but not on SD/glucose 
(-L) agar plate had lost the pSos plasmid while retaining the pMyr-target plasmid. 
These colonies were then used for mating with cdc25Ha yeast cells harboring pSos 
plasmids, including control plasmids and the bait fusion construct. 
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2.6.1.5.2. Yeast mating in 96-well plate 
200 YPAD medium was added to wells of a sterile 96-well plate. 
cdc25Ha segregant containing the pMyr-target plasmid and a colony of the 
appropriate cdc25Ha transformant (produced from single plasmid yeast 
transformation as per manual) into the same well. The process was repeated for each 
of the combinations to be mated. The 96-well plate was incubated at 24.5�C for 24 hr 
with shaking at 250 rpm. 20 [d of each mating culture was spotted on two SD/glucose 
(-UL) and two SD/galactose (-UL) agar plates. For each type of plates, one was 
incubated at 24.5°C and the other was incubated at 37°C. Growth was scored after 
10 days of incubation. Controls were performed in parallel. 
2.6.1.6. Identification of putative interaction partner 
Isolation of pMyr-target plasmid DNA from cdc25Ha was performed. Colonies of 
the yeast plasmid segregant containing pMyr-target plasmid obtained from section 
2.6.1.5.1. were inoculated with 5 mL SD/glucose (-U) liquid medium. The culture 
was incubated at 24.5°C with shaking at 250 rpm until the ODeoo exceeded 1.0. 
1.5 mL of the yeast culture was transferred a 1.5 mL tube. The yeast cells were 
pelleted by centrifugation at 1000 x g for 5 min at room temperature (22-25°C). The 
yeast pellet was resuspended in 0.3 mL yeast lysis solution (2.5 M LiCl, 50 mM 
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Tris-HCl at pH 8.0, 4% Trition X-100 and 62.5 mM EDTA). 50 of acid-washed 
glass beads (0.5 mm) and 300 phenol/chloroform were added to the 1.5 mL tube. 
The contents were mixed by vortexing for 1 min. The suspension was spun at 
13,000 rpm for 5 min at room temperature. The top aqueous phase containing the 
pMyr-partner plasmid DNA was transferred to a new 1.5 mL tube. DNA was 
precipitated with 600 of 100% ice-cold ethanol at -80�C for 15 min. The 
suspension was centrifuged at 13,000 rpm for 10 min at room temperature. The 
supernatant was discarded and the DNA pellet was washed with 1 mL 70% ice-cold 
ethanol. The suspension was centrifuged at 13,000 rpm for 5 min at room 
temperature. The supernatant was discarded and the DNA pellet was allowed to dry 
under air. pMyr-target plasmid DNA was recovered by resuspending the DNA pellet 
in 20 fil nanopure water. The extracted and purified pMyr-target plasmid was 
transformed into chemically competent bacterial cells E. coli strain DH5a, followed 
by small-scale preparation of bacterial plasmid DNA and dideoxy DNA sequencing. 
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CHAPTER 3 Results 
3.1. Transcription start site of the hNP220 gene is located 312 nucleotides 
upstream the initiation codon 
The transcription start site of hNP220 gene was mapped by using nested 
5'-RLM-RACE. A single band of size 250 bp was obtained from the second round 
PGR of the RLM-Racing cDNA procedure in which testis CapSite c D N A T M dT was 
used as PGR template. Dideoxy sequencing of the cloned PGR product revealed that 
the TSS of hNP220 was 312 nucleotides upstream the initiation codon. Our sequence 
is identical to the previously reported hNP220 cDNA (Inagaki et al, 1996) 
(GenBank accession no.: NM—014497.2) except there are two bases truncated at the 
5' end (Figure 3.1). The difference may indicate the presence of multiple 
transcription start sites. 
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Figure 3.1. Determination of the transcription start site of hNP220 using nested 
5'-RLM-RACE. (A) 5'-RLM-RACE. Lane 7: Ikb dsDNA marker; 
lane 2: first round PGR product; lane 3: second round PGR product 
with expected size around 250 bp. (B) Alignment between the 
5' sequence of the first publicly deposited mRNA of hNP220 
(GenBank accession no.: NM_014497.2) and that obtained from 
5,-RLM-RACE. 
A 
bp 1 2 3 
1000 
500 
250 — 
B 
N M _ 0 1 4 4 9 7 . 2 : 1 g c a t g c g t g c a g c t c t t t g g a g g c g g t a g c . . . 
一 I I I I I I M I I I I I I I I M I I M I I I I M 
5‘-RLM-RA C E : _ _ a t g c g t g c a g c t c t t t g g a g g c g g t a g c . . . 
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3.2. Third splice variant of hNP220 gene {hNPllOs) is identified 
In an attempt to clone hNP220 into CytoTrap® two-hybrid bait vector pSos, PGR 
primers NP220-F-Sos and NP220-R-Sos were used to amplify hNP220 from Human 
Heart and Testis Marathon-Ready™ cDNAs (BD Biosciences Clontech, CA). Three 
bands were observed (Figure 3.2). The two bright bands were of expected sizes of 
about 6.0 kb and 3.7 kb, corresponding to hNP220a and hNP2205 respectively. 
Interestingly, an unexpected faint band of size about 4.0 kb was observed. All the 
3 bands were gel purified, cloned into vector pSos, and completely sequenced. The 
faint band sandwiched between the two bright bands was eventually identified as the 
third splice variant of hNP220, designated hNP220s. The novel cDNA sequence of 
hNP220sis shown in Figure 3.3. Schematic alignment of hNP220a, hNP2205 and 
hNP220s cDNAs is depicted in Figure 3.4B. To validate the presence of the two 
junctions in the cDNA of hNP220£ as indicated in the hNP220a-hNP220s 
alignment, RT-PCR using two pairs of primers that could only amplify hNP220a and 
hNP220s but not hNP2205 was performed. Result of RT-PCR provides a cogent 
evidence that the two junctions in the cDNA of hNP2206 do exist in a wide variety 
of human fetal and adult tissues (Figure 3.4A) studied. To further confirm the 
identification of hNP220s was not a result of PGR artifact, Northern hybridization 
was performed. Result of Northern hybridization (Figure 3.5), particularly from lane 
3 (skeletal muscle) of the blot, reveals clearly that hNP220 has three alternatively 
spliced mRNA transcripts of sizes 7.5, 4.4 and 4.0 kb. Expected size of the mRNA 
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transcripts of hNP220oc, hNP220€ and hNP220d 肌 6.6, 4.7 and 4.3 kb respectively. 
The three mRNA transcripts of size 7.5, 4.4 and 4.0 kb detected on the blot are 
believed to be corresponding to hNP220a, hNP220£ and respectively, even 
though there are discrepancies between the size expected and detected. In fact, it 
merits attention that anomalous electrophoretic mobility of RNA in denaturing 
formaldehyde/agarose gel has been reported (Hauge, 1988) and hence the use of blot 
hybridization for RNA size determination remains cautionary. 
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Figure 3.2. PGR of hNP220. PGR primers NP220-F-Sos and NP220-R-Sos were 
used to amplify hNP220 from Human Heart and Testis 
Marathon-Ready™ cDNAs (BD Biosciences Clontech, CA). Three 
bands were observed. All the 3 bands were gel purified, cloned into 
CytoTrap® two-hybrid bait vector pSos, and completely sequenced. 
The faint band sandwiched between the two bright bands was 
eventually identified as the third splice variant of hNP220, designated 
hNP220s. Lane 1: Ikb DNA ladder; lane 2: PGR product of hNP220 
cDNA amplification. 
1 2 
• i 
•m 
6 k b ——， 
3 k b — . ， 
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Figure 3.3. cDNA sequence (GenBank accession no.: AF534078) and predicted 
open reading frame hNP220s. The asterisk indicates the premature 
stop codon as the result of a frameshift. The newly introduced 
40-amino acid long leucine-rich basic leucine-zipper like motif 
(bZLM) at the C-terminal of hNP220s yet not found in hNP220a is in 
bold type. Leucine residues in the bZLM are underlined. 
M S R P R F N P R G D F 
1 g c c a t g t e g a g a c c c a g g t t t a a t c c t c g a g g a g a c t t t 3 9 
P L Q R P R A P N P S G M 
40 c c a c t t c a a a g g c c a cga g c a c c t a a c c c t t c t g g g a t g 78 
R P P G P F M R P G S M G 
79 a g g c c t c c a g g a c c a t t t a t g a g g c c t g g a t c t a t g g g t 117 
L P R F Y P A G R A R G I 
118 c t c c c a a g a t t t t a c cca g c a g g g a g a g c a c g t g g a a t t 15 6 
P H R F A G H E S Y Q N M 
157 c c a c a c a g a t t t g e t g g c c a t g a a t c t t a t c a g a a c a t g 195 
G P Q R M N V Q V T Q H R 
19 6 g g g c c a c a g a g a a t g a a t g t t c a g g t a a c t c a a c a c aga 234 
T D P R L T K E K L D F H 
2 3 5 a c t g a t c c a a g a t t g a c c a a a g a a a a a c t g g a t t t t c a t 27 3 
E A Q Q K K G K P H G S R 
2 7 4 g a a g c a c a a c a g a a g a a g g g g a a g c c t c a t g g t a g e e g g 312 
W D D E P H I S A S V A V 
3 1 3 t g g g a t g a t g a g c c t c a t ata t c t g c a t e a g t g g c a g t g 351 
K Q S S V T Q V T E Q S P 
352 a a a c a g a g t t c t gta aca c a g g t t a c a g a g c a g a g t c c c 3 90 
K V Q S R Y T K E S A S S 
3 91 a a a g t a c a g a g e c g c t a t aca aaa g a g a g t g c c tea agt 429 
I L A S F G L S N E D L E 
430 a t e t t a g c a a g t t t t gga tta t c t a a t g a a g a c eta gaa 4 68 
E L S R Y P D E Q L T P E 
4 6 9 g a a c t t a g t c g c t a t c c t g a t g a a caa e t a a c t c c t gaa 507 
N M P L I L R D I R M R K 
508 a a t a t g cca t t a att t t g a g g g a t ata aga a t g cga aaa 54 6 
M G R R L P N L P S Q S R 
547 a t g g g g c g c cga tta cct a a t t t a c c t t c t c a g a g e aga 585 
N K E T L G S E A V S S N 
58 6 a a t a a a g a a aca ctt g g t a g t gaa g c a g t t t e a a g t aat 62 4 
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V V D Y G H A S K Y G Y T 
6 2 5 g t g g t c g a t t a t g g g c a t g c a a g e a a a t a t g g c t a c a c a 663 
E D P L E V R I Y D P E I 
664 g a a g a t c c a c t t g a a g t a c g t a t t t a t g a t c c t g a a a t t 702 
P T D E V E N E F Q S Q Q 
7 03 c c a a c t g a t g a g g t c g a g a a t g a a t t t c a g t e a c a g c a g 741 
N I S A S V P N P N V I C 
7 4 2 a a c a t t t c t g c a t c t g t t c c c a a t c c a a a t g t g a t a t g t 780 
N S M F P V E D V F R Q M 
7 8 1 a a t t c t a t g t t t c c t g t t g a a g a c g t a t t t c g c caa a t g 819 
D F P G E S S N N R S F F 
8 2 0 g a c t t c c c c g g t g a g t c c t c c a a t a a t e g g t c c t t t t t c 858 
S V E S G T K M S G L H I 
8 5 9 t e a g t t g a g a g t g g a a c c a a g a t g t e a g g c t t a c a c a t t 8 97 
S G G Q S V L E P I K S V 
8 98 t e a g g a g g a c a g t e a g t c c t t g a a c c c a t a a a a t c c g t c 936 
N Q S I N Q T V S Q T M S 
937 a a c c a a t c c a t t a a c caa aca g t t a g e c a g a c a a t g a g t 975 
Q S L I P P S M N Q Q P F 
97 6 c a a t c t c t g a t t c c t cca t c t a t g a a c c a g caa c c t t t t 1014 
S S E L I S S V S Q Q E R 
1 0 1 5 t e g t e g g a a t t a a t t t e a t c t g t a a g e c a g c a a g a g e g g 1053 
工 P H E P V I N S S N V H 
1 0 5 4 a t e c c a c a t g a a c c t g t g a t t a a t t e a t c t a a c g t a c a t 1092 
V G S R G S K K N Y Q S Q 
10 93 g t t g g a t e a aga gga a g t aaa a a g a a t t a c c a g t e a c a g 1 1 3 1 
A D I P I R S P F G I V K 
1 1 3 2 g e t g a c a t t c c c a t t e g g t c t c c c t t t g g t a t t g t g aaa 1170 
A S W L P K F S H A D A Q 
1 1 7 1 g c a t c c t g g eta cca a a g t t t t e a c a t g e t g a t g c c c a g 120 9 
K M K R L P T P S M M N D 
1 2 1 0 a a g a t g a a g aga c t t cca a c t c c t t c t a t g a t g a a t g a t 12 4 8 
Y Y A A S P R I F P H L C 
12 4 9 t a t t a t g c a gca t c t cca aga ata t t t cca c a t t t g t g t 1287 
S L C N V E C S H L K D W 
1 2 8 8 t c t c t g t g t a a c gta gaa t g t a g t c a t t t g a a g g a t t g g 132 6 
工 Q H Q N T S T H I E S C 
1327 a t t c a g c a t caa a a t aca t c t a c t c a c a t t g a g a g e t g t 1365 
R Q L R Q Q Y P D W N P E 
13 6 6 cga c a g tta cgt caa c a g t a t cct g a t t g g a a t cct g a g 1404 
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I L P S R R N E G N R K E 
1 4 0 5 a t e c t c c c a t e g a g a a g a a a t g a g g g c a a t a g a a a a g a a 1 4 4 3 
N E T P R R R S H S P S P 
1 4 4 4 a a t g a a a c t c c a c g a a g a c g t t c t c a t t c c c c c a g t c c t 1 4 8 2 
R R S R R S S S S H R F R 
1 4 8 3 a g g c g t t c t a g a a g a t e a a g e t e a a g t c a c a g a t t c c g t 1 5 2 1 
R S R S P M H Y M Y R P R 
1 5 2 2 e g g t c t c g a a g e c c a a t g c a t t a c a t g t a t a g g c c g aga 15 60 
S R S P R I C H R F I S R 
1 5 6 1 a g t c g a a g t c c a a g a a t t t g c c a t c g t t t c a t t t c t aga 1 5 9 9 
Y R S R S R S R S P Y R 工 
1 6 0 0 t a c a g a t c c a g a t c c aga t c c c g t t e a c c a t a t c g a a t t 1638 
R N P F R G S P K C F R S 
1 6 3 9 a g a a a t c c a t t t a g a g g t a g t cca a a a t g c t t t c g a t e a 167 7 
V S P E R M S R R S V R S 
167 8 g t t a g e c c t g a g a g g a t g t e a a g g a g a t e a g t g a g a t e a 1 7 1 6 
S D R K K A L E D V V Q R 
1 7 1 7 t e a g a t a g a a a a aaa g c a t t a g a a g a t g t a g t a caa cga 1 7 5 5 
S G H G T E F N K Q K H L 
17 5 6 t c t g g g c a t g g g aca gaa t t t a a t a a a c a g a a g c a t c t t 17 94 
E A A D K G H S P A Q K P 
17 95 g a a g e t g e t g a t a a g gga c a t t e a cca g c a caa a a g c c t 1 8 3 3 
K T S S G T K P S V K P T 
1 8 3 4 a a a a c t a g e a g t gga aca aaa cca t e a g t t a a a c c t aca 1872 
S A T K S D S N L G G H S 
18 7 3 a g e g e t a c a a a g a g t g a t t e a a a t e t a g g a g g a c a t t c t 1 9 1 1 
I R C K S K N L E D D T L 
1 9 1 2 a t t c g t t g t aaa t e a a a g a a t c t t g a a g a t g a c a c t t t g 1950 
S E C K Q V S D K A V S L 
1 9 5 1 t e a g a a t g t aaa c a g g t g t c t g a t aaa g e t g t t t c t c t c 198 9 
Q R K L R K E Q S L H Y G 
19 90 c a g c g a a a g c t t e g g aaa gaa c a g t e a t t g c a t t a t g g t 2028 
S V L L I T E L P E D G C 
2 0 2 9 t e g g t t c t t c t t ata a c t gaa t t a cca g a g g a t g g t t g t 2067 
T E E D V R K L F Q P F G 
2 0 6 8 a c t g a a gaa g a t g t g aga aaa tta t t t caa cca t t t g g g 2 1 0 6 
K V N D V L I V P Y R K E 
2 1 0 7 a a a g t g a a t g a t g t c eta a t t g t t cca t a t aga aaa g a g 2145 
A Y L E M E F K E A I T A 
214 6 g e t t a c eta gaa a t g gaa t t t aaa g a g g c a a t t a c t gca 2184 
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I M K Y I E T T P L T I K 
2 1 8 5 a t t a t g a a g t a c a t t g a a a c a a c a c c t c t t acq a t a a a a 2 2 2 3 
G K S V K I C V P G K K K 
2 2 2 4 g g a a a a a g t g t g a a a a t a t g t g t t c c a g g a a a g a a a a a a 22 62 
A Q N K E V K K K T L E S 
2 2 63 g c a c a g a a c a a a g a g g t g a a g a a a a a g a c t t t a g a g t e a 2 3 0 1 
K K V S A S T L K R D A D 
2 3 0 2 a a g a a a g t a t c t g c a t c t a c c t t a a a a a g a g a t g c a g a t 2 3 4 0 
A S K A V E I V T S T S A 
2 3 4 1 g e t t e a a a a g e t g t t g a a a t t g t t a c t t e a a c t t c t g e t 237 9 
A K T G Q A K A S V A K V 
2 3 8 0 g c c a a a a c t g g a caa g c c a a g g c a t c t g t a g c c a a a gta 2 4 1 8 
N K S T G K S A S S V K S 
2 4 1 9 a a c a a a t c t a c a g g g a a a t e a g c g a g t t c t g t a a a a t c t 2457 
V V T V A V K G N K A S I 
2 4 5 8 g t g g t a a c g g t a g e t g t t a a a g g t a a t a a a g e t t e a a t e 24 96 
K T A K S G G K K S L E A 
2 4 97 a a a a c a g c a a a a t c t g g t gga a a g a a g t c t e t a g a a g c c 2 5 3 5 
K K T G N V K N K D S N K 
2 53 6 a a a a a g a c t g g g a a t g t c a a a a a c a a a g a c t c t a a c aaa 257 4 
P V T I P E N S E I K T S 
2 5 7 5 c c t g t g a c t a t a cca gaa a a c t c t g a a a t a a a g a c c a g t 2 613 
I E V K A T E N C A K E A 
2 614 a t t g a a g t c aaa g c c a c t g a a a a c t g t g e t a a a gaa g e t 2 652 
工 S D A A L E A T E N E P 
2 6 5 3 a t t t c t g a t g e t g e t t t g g a g g c c a c a g a g a a t g a a cca 2 691 
L N K E T E E M C V M L V 
2 692 c t t a a c a a g gaa aca gaa g a a a t g t g t g t g a t g c t t g t c 2 7 3 0 
S N L P N K G Y S V E E V 
2 7 3 1 t c t a a t t t g c c t a a t aaa gga t a t t c t g t a g a a g a a g t t 27 69 
Y D L A K P F G G L K D I 
2 7 7 0 t a t g a c t t a g c a aaa cca t t t g g t g g t t t a a a g g a t a t e 2808 
L I L S S H K K A Y I E I 
2 8 0 9 t t g a t t t t a t e a t c t c a t aaa a a g g c a t a t ata gaa ata 2847 
N R K A A E S M V K F Y T 
2 8 4 8 a a t a g a aaa g e t g e t g a g t c t a t g gta aaa t t t t a t a c c 288 6 
C F P V L M D G N Q L S I 
2 8 8 7 t g c t t c cca gta t t g a t g g a t gga a a t caa c t c tea ata 2 9 2 5 
S M A P E N M N I K D E E 
2 9 2 6 a g t a t g g e t c c t gaa a a c a t g a a t ata a a a g a t g a g gaa 2964 
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A I F I T L V K E N D P E 
2 9 6 5 g e t a t a t t t a t a a c c t t g g t a a a a g a a a a t g a c c c a g a g 3 0 0 3 
A N I D T I Y D R F V H L 
3 0 0 4 g c a a a c a t a g a t a c a a t t t a t g a t c g a t t t g t a c a t c t t 3 0 4 2 
D N L P E D G L Q C V L C 
3 0 4 3 g a t a a t t t a c c g g a a g a t g g a c t t c a g t g t g t a c t t t g t 3 0 8 1 
V G L Q F G K V D H H V F 
3 0 8 2 g t t g g a c t t c a g t t t g g a a a a g t g g a t c a c c a t g t a t t c 3 1 2 0 
工 S N R N K A I L Q L D S 
3 1 2 1 a t a a g t a a t a g a a a c a a g g c a a t t c t t c a g t t a g a t a g t 3 1 5 9 
P E S A Q S M Y S F L K Q 
3 1 6 0 c c t g a a t c t g e t c a g t e a a t g t a t a g e t t t c t g a a a caa 3 1 9 8 
N P Q N I G D H M L T C S 
3 1 9 9 a a t c c a c a a a a t a t t g g t g a c c a t a t g t t g a c c t g c t e a 3237 
L S P K I D L P E V Q I E 
3 2 3 8 t t a t c t c c a a a g ata g a c t t a c c a g a g g t g c a a a t t g a a 32 7 6 
H D P E L E K E R L W L S 
3 2 7 7 c a t g a c c c a g a a t t a gaa a a a g a a a g a c t t t g g c t g a g e 3 3 1 5 
K T L R I L K A L L V E V 
3 3 1 6 a a a a c a e t a a g a a t e eta aaa g c a e t a c t g g t a g a a g t t 3354 
P N & K R S H Y F H & I W 
3 3 5 5 c c a a a t e t a a a g a g g a g e c a t t a t t t c c a t t t a a t t t g g 3 3 9 3 
M N L L L W M R L * 
3 3 9 4 a t g a a t t t g t t a c t g t g g a t g a g g t t a t a g a a g a a g tga 34 32 
3 4 3 3 a t e c t t c t c a g g cca a g e aga a t e c a c t a a a g g gaa aaa 3 4 7 1 
3 4 7 2 g g a a a g a a a c t c t e a aaa a t g t t c c t t t c t c t g a a c tta 3510 
3 5 1 1 a c t t a a a g a aga aaa a g g gga aaa c t t c c a c t c c t c g t g 354 9 
3 5 5 0 g t g t t g a g g g a g a a c t a t c t t t t g t g a c a t t g g a t g aga 358 8 
358 9 t t g g g g a a g a g g a a g a t g c a g c t g c a c a t e t a g c a c a a g 3 627 
3 6 2 8 c t c t a g t e a c t g t g g a t g a a g t a a t t g a t g a a g a a g a a c 3 666 
3 6 6 7 t a a a t a t g g a a g aaa t g g t a a a a c t c c a a c caa g a g a g t 3705 
37 0 6 t a g a a t t g g gaa a a c t c t g c c a t e aga a a a a g e t g t t g t 37 4 4 
37 4 5 g a c a g a a c c a g e aaa a g g cga aga g g c c t t cca g a t g a g 37 8 3 
3 7 8 4 t g a a g t t g a t g a gga a t e t g g a t t aaa g g a t t c aga a c c 3822 
3 8 2 3 a g a g c g aaa a c g caa gaa g a c t g a a g a c t c t t c t t c a g g 38 61 
38 62 c a a a t e a g t g g c g t c t g a t g t c c c t g a g g a a t t aga c t t 3900 
3 9 0 1 t c t t g t a c c t a a g g c t g g a t t c t t c t g t c c a a t t t g t t c 3 9 3 9 
3 94 0 c c t c t t eta c t c a g g tga aaa a g e a a t g a c aaa t e a ctg 3 97 8 
397 9 caa g a g t a c a c g tea taa gca aaa t a c tga g a a a t t cat 4 017 
4 018 g g c caa gca a a g aaa gga aaa gga gca gaa tga g g c tga 4 05 6 
4 057 aga a a g a a g c t c t a g g t g a 4 07 5 
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Figure 3.4. Expression pattern of hNP220 in human fetal and adult tissues by 
RT-PCR. (A) RT-PCR. Human fetal and adult Multiple Tissue cDNA 
(MTC ) Panels purchased from Clontech (BD Biosciences Clontech, 
CA) were used. (B) Schematic diagram of the priming sites of PGR 
primers used in RT-PCR. 
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Figure 3.5. Expression pattern of hNP220 in human adult tissues by Northern 
hybridization. Predicted size of the mRNA transcripts of hNP220a, 
hNP220s and hNP220S are 6.6 kb, 4.7 kb and 4.3 kb respectively. 
Pre-normalized Human 12-Lane Multiple Tissue Northern (MTN®) 
Blot purchased from Clontech (BD Biosciences Clontech, CA) was 
used. Lane 1: brain; lane 2: heart; lane 3: skeletal muscle; lane 4: 
colon; lane 5: thymus; lane 6: spleen; lane 7: kidney; lane 8: liver; 
lane 9: small intestine; lane 10: placenta; lane 11: lung; lane 12: 
peripheral blood. 
kb 1 2 3 4 5 6 7 8 9 10 11 12 
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3.3. In silico analysis of hNP220s 
The cDNA of hNP220s has a predicted open reading frame (ORF) containing 1139 
amino acids (Figure 3.3). Domain structure of hNP220s resembles that of hNP220a, 
except for the deletion of DNA-binding, AR and MH3 domains and the introduction 
of a C-terminal leucine-rich basic leucine-zipper like motif (bZLM) as the result of a 
frameshift and a premature stop codon in the hNP220s transcript. A schematic 
diagram showing the domain organization of hNP220a, hNP2206 and hNP220s is 
depicted in Figure 3.6A. Molecular weight, theoretical pi and amino acid 
composition were estimated using ProtParam accessible via 
http://us.expasy.org/tools/protparam.html (Appel et al., 1994) (Table 3.1). 
hNP220s has a predicted molecular weight of 128.5 kDa and a theoretical pi of 9.57. 
Both hNP2208 and hNP2206 are basic proteins with theoretical pi of 9.57 and 9.23 
respectively whereas hNP220a is an acidic protein with theoretical pi of 6.02. The 
basicity of hNP220s and hNP2205 is believed to be caused by the absence of acidic 
repeats (AR) domain. Amino acid composition of hNP220s is tabulated in Table 3.1. 
Resembling hNP220a, hNP220s contains a high proportion of serine and positively 
charged amino acids arginine and lysine. Calculated charge distribution of hNP220s 
by SAPS (Statistical Analysis of Protein Sequences) (Brendel, et al., 1992), 
accessible via http://us.expasy.org, unearths a positive charge cluster from residue 
position 485 to 576, corresponding to the arginine/serine-rich domain (RS) 
(Figure 3.8). Hydrophobicity and hydrophilicity plots using Kyte-Doolittle and 
5 4 
Results 
Hopp-Woods scales with different window sizes reveal that hNP220s is a hydrophilic 
protein without large localized hydrophobic region (Figure 3.8, Figure 3.9, 
Figure 3.10). As shown in Figure 3.3, as the result of a frameshift, there is a newly 
introduced leucine-rich bZIP-like motif at the C-terminal of hNP220s not found in 
hNP220a. Yet, computational approach using 2ZIP server (Bomberg-Bauer et al., 
1998), accessible via http://us.expasy.org, identified no leucine zipper domain in 
hNP220s. A typical potential leucine zipper contains a repeat of leucine residues 
every 7 position with a coiled coil structure. Motif searching of the bZLM against 
PROSITE database (Bairoch et al., 1997) using PROSCAN, accessible via 
http://us.expasy.org, returned only a match corresponding to protein kinase C 
phosphorylation site (Figure 3.11). Predicted nuclear localization signals (NLSs) of 
hNP220s using PSORT II, accessible via http://us.expasy.org, were found and listed 
in Table 3.3. Predicted subcellular localization of hNP220s is nucleus with a 
possibility of 70%. This is as expected since predicted NLSs found in hNP220s are 
located at the N-terminal and all the 3 isoforms of hNP220, namely hNP220a, 
hNP2206 and hNP220s, share the same N-terminal domain organization up to the 
MH2 domain. 
55 
Results 
Figure 3.6. Domain organization comparison among hNP220a, hNP2206 and 
hNP220s. (A) Schematic diagram showing the domain structure of 
hNP220a, hNP2205 and hNP2208. (B) Color codes used for the 
representation of hNP220 domains. 
A 
N-terminal C-terminal 
hNP220a • • • ^ ^ m • mmmm B H 
hNP2205 • • • • 
hNP220s • • • ^ ^ • 
Not drawn in scale 
B 
Matrin 3 homologous Matrin 3 homologous Acidic repeats 
region 1 (MH1) region 2 (MH2) (ARs) 
Arginine/serine rich DNA-bindina Matrin 3 homologous 
(RS) “ region 3 (MH3) 
Zinc finger motif • Basic leucine-zipper 
like motif (bZLM) 
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Table 3.1. In silico study of hNP220s protein. Molecular weight, theoretical pi 
and amino acid composition were calculated using ProtParam 
accessible via http://us.expasy.org/tools/protparam.html (Appel et al., 
1994). 
Number of amino acids : 1139 
Molecular weight : 128.5 kDa 
Theoretical pi : 9.57 
Amino acid composition (in descending order of % composition) 
Ser(S) 136 11.9 Gly (G) 51 4.5 
Lys(K) 95 8.3 Gin (Q) 51 4.5 
Glu (E) 80 7.0 Thr (T) 48 4.2 
Pro (P) 80 7.0 Asp (D) 47 4.1 
Arg(R) 80 7.0 Phe (F) 34 3.0 
Leu (L) 79 6.9 His (H) 32 2.8 
Val (V) 69 6.1 Met (M) 32 2.8 
Asn (N) 59 5.2 Tyr (Y) 27 2.4 
Ala (A) 58 5.1 €ys (C) 17 1.5 
He (I) 57 5.0 Trp(W) 7 0.6 
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Figure 3.7. Charge distribution of hNP220s amino acid sequence. Calculation was 
done using SAPS (Statistical Analysis of Protein Sequences) (Brendel, 
et al., 1992) accessible via http://us.expasy.org. Positive charge cluster 
is shaded in grey. 
1 0 0 + 0 + 0 0 0 + 0 - 0 0 0 0 + 0 + 0 0 0 0 0 0 0 + 0 0 0 0 0 0 + 0 0 0 0 0 0 0 + 0 0 0 0 0 + 0 + 0 000+0000-0 
61 0 0 0 0 0 0 0 + 0 0 000000+0-0 +00+-+0-00 -000++0+00 0 0 + 0 — — 0 0 0 0 0 0 0 0 0 + 0 0 0 
121 0 0 0 0 0 - 0 0 0 + 000+00+—00 0 0 0 0 0 0 0 0 0 0 0—一0—一0〇+〇 0 - - 0 0 0 0 - 0 0 0 0 0 0 + - 0 + 0 + 
181 + 0 0 + + 0 0 0 0 0 000+0+—000 0-0000000- 0 0 0 0 0 + 0 0 0 0 --00-0+00- 0-000--0-0 
2 4 1 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 + 0 0 - 0 0 0 - 0 0 0 0 + 0 0 0 0 0 - 0 0 0 + 0 0 0 0 0 0 0 0 
301 0 0 0 0 0 - 0 0 + 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 00000000—+ 0 0 0 - 0 0 0 0 0 0 
361 0 0 0 0 0 0 + 0 0 + + 0 0 0 0 0 0 - 0 0 0 + 0 0 0 0 0 0 + 0 0000+0000-〇〇+0++〇〇〇0 0 0 0 0 - 0 0 0 0 0 
421 0 + 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 + - 0 0 0 0 0 0 0 0 0 0 0 - 0 0 + 0 0 + 0 0 0 0 - 0 0 0 - 0 0 0 0 + + 0 - 0 0 + + -
481 0 - 0 0 + + + 0 0 0 0 0 0 + + 0 + + 0 0 0 0 0 + 0 + + 0 + 0 0 0 0 0 0 0 + 0 + 0 + 0 0 + 0 0 0 + 0 0 0 + 0 + 0 + 0 + 0 + 
541 | i i i | i | i | f | | | | l ^ 0-- 000 + 0 0 0 0 0 - 00 + 0 + 00-00 
6 0 1 一 + 0 0 0 0 0 0 + 0 + 0 0 0 0 0 + 0 0 0 + 0 0 0 0 0 + 0 - 0 0 0 0 0 0 0 0 + 0 + 0 + 0 0 — — 0 0 0 - 0 + 0 0 0 - + 0 0 
6 6 1 0 0 0 + + 0 + + - 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 一 一 0 0 0 - 一 一 0 + + 0 0 0 0 0 0 + 0 0 - 0 0 0 0 0 0 + + - 0 0 0 - 0 -
7 2 1 0 + - 0 0 0 0 0 0 + 0 0 - 0 0 0 0 0 0 + 0 + 0 0 + 0 0 0 0 0 + + + 0 0 0 + - 0 + + + 0 0 - 0 + + 0 0 0 0 0 0 + + - 0 - 0 
781 0 + 0 0 - 0 0 0 0 0 0 0 0 + 0 0 0 0 + 0 0 0 0 + 0 0 + 0 0 0 + 0 0 0 0 0 + 0 0 0 0 0 0 0 + 0 0 + 0 0 0 + 0 0 + 0 0 0 + + 
841 〇〇一0++〇〇00 +0+—00+000 0 0 - 0 0 - 0 + 0 0 0 - 0 + 0 0 - 0 0 0 + - 0 0 0 - 0 0 0 - 00—0—000+— 
901 0 - - 0 0 0 0 0 0 0 0 0 0 0 + 0 0 0 0 - - 0 0 - 0 0 + 0 0 0 0 0 + - 0 0 0 0 0 0 0 + + 0 0 0 - 0 0 + + 0 0 - 0 0 0 + 0 0 
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M i x e d c h a r g e c l u s t e r s (cmin = 18/30 or 2 5 / 4 5 or 31/60) : none 
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Figure 3.8. Hydrophobicity plot of hNP2208 protein using ProtScale accessible 
via http://us.expasy.org/cgi-bin/protscale.pL Scale: Kyte-Doolittle; 
window size: 7. Kyte-Doolittle scale with a window size of 7 can 
yield a plot suitable for finding putative surface-exposed regions. 
Individual values for the 20 amino acids used in the Kyte-Doolittle 
(KD) scale are listed in Table 3.2. 
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Figure 3.9. Hydrophobicity plot of hNP220s protein using ProtScale accessible 
via http://us.expasy.org/cgi-bin/protscale.pL Scale: Kyte-Doolittle; 
window size: 19. Kyte-Doolittle scale with a window size of 19 can 
yield a plot in which transmembrane domains, if any, stand out 
sharply. Individual values for the 20 amino acids used in the 
Kyte-Doolittle (KD) scale are listed in Table 3.2. 
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Figure 3.10. Hydrophilicity plot of hNP220s protein using ProtScale accessible via 
http://us.expasy.org/cgi-bin/protscale.pl. Scale: Hopp-Woods; window 
size: 7. Hopp-Woods scale with a window size of 7 can yield a plot in 
which the region of maximal hydrophilicity is likely to be an antigenic 
site. Individual values for the 20 amino acids used in the Hopp-Woods 
(HW) scale are listed in Table 3.2. 
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Table 3.2. Individual values for the 20 amino acids used in the Kyte-Doolittle (KD) 
and Hopp-Woods (HW) scales. 
KD HW 
A l a n i n e 1.8 -0.5 
A r g i n i n e -4,5 3.0 
A s p a r a g i n e -3.5 0.2 
A s p a r t i c acid -3.5 3.0 
Cysteine 2.5 -1.0 
G l u t a m i n e -3.5 0 .2 
G l u t a m i c acid -3.5 3 . 0 
Glycine -0.4 0.0 
Histidine -3.2 -0.5 
Isoleucine 4.5 -1.8 
Leucine 3.8 -1.8 
Lysine -3.9 3.0 
M e t h i o n i n e 1. 9 -1.3 
Phenylalanine 2.8 -2.5 
Proline -1.6 0.0 
Serine -0.8 0.3 
Threonine -0.7 -0.4 
Tryptophan -0.9 -3.4 
Tyrosine -1.3 -2.3 
Valine 4 . 2 -1.5 
6 2 
Results 
Figure 3.11. In silico analysis of the newly introduced leucine-rich basic 
leucine-zipper like motif (bZLM) as the result of a frameshift at the 
C-terminal of hNP2208 (residues 1100-1139). (A) One-dimensional 
protein structure predicted by profile based neural networks using 
PROF accessible via http://us.expasy.org. (B) Motif searching against 
PROSITE database (Bairoch et al., 1997) using PROSCAN accessible 
via http://us.expasy.org. Leucine residues are in bold type. 
A 
1100 1 1 3 9 
AA RLWLSKTLRILKALLVEVPNLKRSHYFHLIWMNLLLWMRL 
〇BS—sec 
PROF—sec HHHHHHHHHHHH HHHHHHHHHHHHHHHH 
Rel—sec 3 2 1 2 3 3 1 0 2 4 6 6 5 0 0 0 1 0 1 1 1 2 3 1 6 7 8 7 7 7 7 6 6530 32 0 0 1 0 0 3 55 67 8 8 8 7 8 7 7 6218 
SUB sec IBB BBBBBBBBBBI BBBBBHBBBBBBI. 
〇—3—acc b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b 
P—3—acc e e e e e e e e e e e e e e e e b e e b e b b b b e e ee e b b b b b b b b b b b b b b e e 
Rel—acc 0 30 3 1 1 3 1 1 0 3 0 1 1 3 2 2 3 4 1 2 1 1 3 3 2 2 3 1 3 3 1 3 4 2 3 3 2 42 3 2 1 3 2 4 4 6 99 97 9 6 6 0 1 3 2 
SUB—acc I S.…量 BBBBBBBBBBI. • . . 
B 
R L W L S K T L R I L K A L L V E V P N L K R S H Y F H L I W M N L L L W M R L 
Protein kinase C phosphorylation site 
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Table 3.3. Prediction for nuclear localization signals (NLSs) of hNP220s protein 
using PSORT II accessible via http://us.expasy.org. 
Prediction for nuclear localization signals: 
pat4 PRRR 484-487 
pat7 PRRRSHS 484-490 
pat7 PSPRRSR 491-497 
pat7 PRRSRRS 493-499 
pat7 PGKKKAQ 749-755 
bipartite RRNEGNRKENETPRRRS 472-488 
bipartite RRSRRS S S SHRPRRSRS 494-510 
k 二 9173 
69.6 %: nuclear 
17.4 %: cytoplasmic 
8.7 %: mitochondrial 
4.3 %: endoplasmic reticulum 
» prediction for QUERY is nuc (k=23) 
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3.4. hNP220a and hNP220s are ubiquitously expressed in human fetal and 
adult tissues 
Expression pattern of the mRNA transcripts of hNP220a and hNP220s were 
determined using RT-PCR and Northern hybridization with a single cDNA probe. In 
RT-PCR, two pairs of primers that could only amplify hNP220a and hNP220s but 
not hNP220S mRNA transcripts were used. Predicted size of the PCR amplicons of 
hNP220a and hNP220s are 1.5 kb and 300 bp respectively for the 
MTC-3480-F/MTC-4999-R primer pair, and 1.0 kb and 380 bp respectively for the 
MTC-4981-F/MTC-6000-R primer pair. In Northern hybridization, predicted size of 
the mRNA transcripts of hNP220cx, hNP220s and hNP220S are 6.6 kb, 4.7 kb and 
4.3 kb respectively. Generally speaking, results from Northern hybridization 
(Figure 3.5) and RT-PCR (Figure 3.4) agreed with each other. Based on RT-PCR, 
hNP220a and hNP220s mRNA transcripts are ubiquitously expressed in a wide 
variety of human fetal and adult tissues including but not limited to brain, heart, 
kidney, liver, lung and skeletal muscle. Based on Northern hybridization, on the other 
hand, hNP220a mRNA transcript is highly expressed in skeletal muscle, 
intermediately expressed in brain, heart, colon, spleen, kidney, liver, small intestine, 
placenta and lung, and barely expressed in thymus and peripheral blood. In contrast, 
the expression level of hNP220s mRNA transcript is much lower than that of 
hNP220a in all human adult tissues studied, and is marginally detected in skeletal 
muscle, liver and placenta. These findings qualitatively suggest that hNP220a and 
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hNP220s mRNA transcripts are ubiquitously expressed in a wide variety of human 
fetal and adult tissues even though the expression level of hNP220s mRNA transcript 
is significantly well below that of hNP220a. The much higher sensitivity of RT-PCR 
may account for any discrepancy observed between the results generated by RT-PCR 
and Northern hybridization. 
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3.5. hNP220s shows a punctate subnuclear localization pattern in HepG2 cell 
line 
Subcellular localization pattern of hNP220s in HepG2 cell line was visualized by 
GFP tagging and examined using epz-fluorescence microscopy. Cell nuclei were 
counterstained with a commonly used nucleus marker DAPI which binds to the 
minor groove of DNA, preferably to a cluster of dinucleotides AT. hNP220s was 
found to have a punctate subnuclear localization pattern, excluding nucleoli 
(Figure 3.12). 
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Figure 3.12. hNP2208 shows a punctate subnuclear localization pattern, excluding 
nucleoli, in HepG2 cell line as revealed by GFP 咖-fluorescence 
microscopy. 
GFP Channel DAPI Channel Overlay 
• • • 
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3.6. hNP2208 interacts with MAPREl 
pSos-hNP220s bait fusion construct was used to screen a CytoTrap® XR HeLa Cell 
cDNA Library in an assay using CytoTrap® two-hybrid system. hNP220s and 
MAPREl were found to interact with each other in vivo in yeast Saccharomyces 
cerevisiae strain cdc25H. Such an interaction was identified by the ability of the 
yeast colony harboring both pSos-hNP220s and pMyr-MAPREl (from CytoTrap® 
XR HeLa Cell cDNA Library) fusion constructs to grow at 37°C on SD/galactose 
(-UL) agar plate but not at 37°C on SD/glucose (-UL) agar plate. Result of complete 
sequencing of the rescued pMyr-MAPREl target fusion construct reveals that 
residues from position 181-268 of MAPREl, which is 268-amino acid long, is 
involved in the protein-protein interaction with hNP220s. Positive and negative 
controls were performed in parallel as shown in Figure 3.13. 
6 9 
Results 
Figure 3.13. hNP220s and MAPREl interact in vivo in yeast Saccharomyces 
cerevisiae strain cdc25H. CytoTrap® two-hybrid system and mating of 
single plasmid yeast transformants were used. Growth was scored 
after 10 days of incubation at 37°C on SD/galactose (-UL) agar plate. 
Plasmid combinations for each set of yeast mating were as follows: (A) 
pSos-hNP220s + pMyr-MAPREl. (B) pSos-hNP220s + pMyr (bait 
auto-activation control). (C) pSos-hNP220s + pMyr-MAFB (bait 
fortuitous interaction control). (D) pSos + pMyr-MAPREl (prey 
auto-activation control). (E) pSos-MAPB + pMyr-MAPREl (prey 
fortuitous interaction control). (F) pSos-MAFB + pMyr-MAPB 
(positive control). (G) pSos-MAFB + pMyr-Lamin C (negative 
control). (H) pSos + pMyr (yeast revertant control). 
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CHAPTER 4 Discussion 
4.1. Identification QihNP220s, the third splice variant of hNP220 gene 
The third splice variant of hNP220 gene was isolated from a pool of human heart and 
testis cDNAs. Its existence was verified by RT-PCR, Northern hybridization and a 
human EST sequence (GenBank accession no.: BG429602.1). It is therefore 
convincingly true that hNP220s is not a cloning or PCR artifact. The cDNA of 
hNP220£ has a predicted open reading frame (ORF) containing 1139 amino acids 
(Figure 3.3). Domain structure of hNP220s resembles that of hNP220a, except for 
the deletion of DNA-binding, AR and MH3 domains and the introduction of a 
C-terminal leucine-rich basic leucine-zipper like motif (bZLM) as the result of a 
frameshift and a premature stop codon. The existence of different mRNA splice 
variants as a result of alternative splicing that leads to a frameshift has been reported 
in such human genes as human prolactin receptor gene (Kline et al, 1999) and FHLl 
gene (Ng et al, 2001). A schematic diagram comparing the domain organization of 
hNP220a, hNP2205 and hNP220s is illustrated in Figure 3.6A. As shown in 
Figure 3.3, as the result of a frameshift, there is a newly introduced 40-amino acid 
long leucine-rich bZIP-like motif (bZLM) at the C-terminal of hNP220s yet not 
found in hNP220a. This bZLM was searched against the non-redundant protein 
database at NCBI using BLASTP, and the search revealed no significant sequence 
homology to other proteins. Computational approach using 2ZIP server 
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1998) identified no leucine zipper domain in hNP2208. Motif searching of the bZLM 
against PROSITE database (Bairoch et al., 1997) using PROSCAN returned only a 
match corresponding to protein kinase C phosphorylation site (Figure 3.11). At first 
glance, the lack of sequence homology of the newly introduced bZLM against 
current public protein databases may look odd and cause one to question the validity 
of the newly introduced sequence. However, it should be noted that similar 
observation has been reported in the identification of other novel alternatively spliced 
isoforms of human genes such as neurofibromatosis type 2 tumor suppressor gene in 
which the additional C-terminal 46-amino acid sequence in its isoform Merl51, 
produced as the result of a frame shift, has no significant match to any known protein 
sequences as well (Schmucker et al., 1999). Interestingly, it has also been reported 
that bZLM is present in hnRNP C (McAfee et al., 1996; Tan et al., 2001; 
Koloteva-Levine et al., 2002) in which the bZLM is a key player in RNA binding. 
All in all, since hNP220 is believed to be involved in RNA processing and closely 
related to the family of hnRNPs, it is highly likely that the bZLM in hNP220s is not 
an artifact. The deletion of both the DNA-binding domain and MH3 domain in which 
a Cys2-His2 DNA-binding zinc finger is present, and the introduction of bZLM 
possibly involved in RNA-binding suggests hNP220s is a very interesting candidate 
protein with potential RNA-binding property. Here, on the basis of domain 
organization, we speculate that hNP220s may reflect a dual nucleic acid binding 
property among the isoforms of hNP220: DNA+RNA and RNA-only, in which 
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hNP220a and hNP2206 bind to both DNA and RNA whereas hNP220s binds to 
RNA only. This duality may be important in the previously proposed functions of 
hNP220 in the packaging, splicing and retention of RNA. 
Results from RT-PCR and Northern hybridization reveal that hNP220a and hNP220s 
mRNA transcripts are ubiquitously expressed in a wide variety of human fetal and 
adult tissues even though the expression level of hNP220s is significantly well below 
that of hNP220a. Unlike other proteins such as FHLl and glucose transporter, of 
which both have differences in mRNA tissue expression specificity among splice 
variants, hNP220a and hNP220s are expressed in virtually all human tissues 
examined. The ubiquitous mRNA expression patterns of hNP220a and hNP220s 
indicate that both of them may have linkage to biological functions that are 
fundamental and common in all cell types, and their overlapping expression patterns 
infer that their biological functions may be, to a certain extent, mutually 
complementing each other. 
4.2. Biological resemblance between hNP220a (hNP220) and hNP220s 
As shown in Figure 3.6A, the domain organization of hNP220s is nearly identical to 
that of the N-terminal of hNP220a, except for the bZLM. The close resemblance 
suggests that these two isoforms of hNP220 may, to some extent, share similar 
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biological behaviour and functions with each other. This supposition is supported by 
the similitude between the punctate subnuclear localization patterns of hNP220a and 
hNP2208 as shown in Figure 3.12, and the high resemblance of the expression 
patterns of hNP220a and hNP2206 mRNA transcripts in RT-PCR and Northern 
hybridization as shown in Figure 3.4 and Figure 3.5 respectively. Our proposed close 
biological resemblance between hNP220a and hNP220s means it is possible to 
investigate the biological functions of hNP220 indirectly through the study of 
hNP220s. Alternatively, biological functions observed in hNP220s is likely to be 
present in hNP220a (hNP220) as well. 
4.3. Protein-protein interaction between hNP220s and MAPREl 
In an attempt to extend the current hNP220-FHL2 protein interaction map and/or to 
link hNP220 to component(s) of other signaling pathway(s), CytoTrap® XR HeLa 
Cell cDNA Library screening was performed to fish out potential protein interaction 
partner(s) of hNP220s. After library screening, small-scale yeast mating for 
interaction verification, and yeast plasmid extraction and sequencing, 
microtubule-associated protein, RP/EB family, member 1 (MAPREl) was singled 
out and found to interact with hNP220s in vivo in yeast Saccharomyces cerevisiae 
strain cdc25H. The subcellular localization of the hNP220s-MAPREl interaction in 
mammalian cells remains unknown. MAPREl, in turn, interacts around cytoplasmic 
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microtubules with the C-terminal of tumor suppressor adenomatous polyposis coli 
(APC), a domain which is often truncated in familial and sporadic forms of 
colorectal cancer (Su et al., 1995). APC, in turn, interacts with the key mediator of 
the Wnt signaling pathway, p-catenin, in cytoplasm (Rubinfeld et al., 1993). Effect 
of APC on colorectal carcinoma has been shown to be caused by regulating the level 
of P-catenin in Wnt signaling pathway, affecting the transcription of several 
Wnt-responsive oncogenic proteins including but not limited to c-myc (He et al., 
1998) and c-jun (Mann et al., 1999) and resulting in chromosomal instability. On the 
other hand, it has been found that FHL2 interacts with the C-terminal of hNP220 in 
nucleus (Ng et al., 2002). FHL2, in turn, interacts with P-catenin, supposedly in 
nucleus as well. FHL2 has also been shown to activate P-catenin-dependent 
transcription under Wnt signal in epithelial cells (Wei et al., 2003) while it has a 
down-regulating effect in myoblasts (Martin et al., 2002), suggesting a 
tissue-specific and tissue-dependent regulation of p-catenin by FHL2. The protein 
interaction map among hNP220, MAPREl, APC, p-catenin and FHL2 is 
summarized and depicted in Figure 4.1. Based on the hNP220s-MAPRE 1 interaction, 
potential roles of hNP220 in the regulation of chromosome stability and oncogenesis 
are discussed later. 
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Figure 4.1. Protein interaction map among hNP220, MAPREl, APC, P-catenin 
and FHL2. Interactions with FHL2 and MAPREl suggest hNP220 
may play a role in oncogenesis in concert with or under the control of 
the Wnt signaling cascade. 
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4.3.1. MAPREl protein 
Alternatively known as EB1, microtubule-associated protein, RP/EB family, member 
1 (MAPREl), is a 30 to 35 kDa protein first identified using yeast two-hybrid system 
by its ability to interact with the C-terminal of tumor suppressor adenomatous 
polyposis coli (APC), a domain which is often truncated in familial and sporadic 
forms of colorectal cancer in which the defect chromosomal instability is observed in 
a majority of cases (Su et al., 1995). APC, in turn, interacts with p-catenin which is a 
key mediator of the Wnt signaling pathway. MAPREl protein is present in virtually 
every cell type examined thus far (for review sees Tirnauer and Bierer, 2000). In 
human, there are three MAP RE genes: MAPREl, MAPRE2 and MAPRE3 coding for 
proteins EBl, RPl and EBF3 respectively (Su and Qi, 2001). MAPREl interacts 
with cytoplasmic microtubules, especially the growing plus ends, in interphase, and 
the centrosome and mitotic spindle apparatus in mitosis (Berrueta et al., 1998). This 
protein also associates with pi50, p50/dynamitin and intermediate chain of dynein of 
the dynactin complex. (Berrueta et al., 1999). Its yeast homologues, Mai3 and Bimlp, 
have long been found to be important in microtubule dynamics, cytokinesis 
checkpoint, mitotic spindle positioning and segregation of episomes (Su and Qi, 
2001). It is, therefore, strongly believed that MAPREl is involved in microtubule 
polymerization, cell polarity, and chromosome stability and segregation (for review 
sees Tirnauer and Bierer, 2000). 
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4.3.2. Wnt signaling pathway 
Also known as APC/p-catenin signaling pathway, Wnt signaling pathway is 
implicated in biological processes as diverse as oncogenesis, cell-to-cell interactions 
during embryo gene sis, control of asymmetric cell division and CNS patterning. The 
first Wnt gene, known as mouse Wnt-1, was discovered as a proto-oncogene in 
mouse mammary tumor in 1982 (Nusse and Varmus, 1982). Since then, about 100 
Wnt genes have been identified and characterized. Insights into the mechanisms of 
Wnt signaling pathway are gained from 3 model systems: genetics in Drosophila and 
C. elegans; biochemistry in cell culture and ectopic gene expression in Xenopus 
embryos; gene knockouts in M. muscuius (for review sees Wodarz and Nusse, 1998). 
From these models, it became increasingly clear and well understood that Wnt genes 
are important players in cell development. 
A two-state model of Wnt signaling pathway has been proposed and is depicted in 
Figure 4.2. Without a Wnt signal, dishevelled is inactive (Dshj) and Drosophila 
Zeste-white 3 or its human homolog glycogen synthase kinase 3 (Zw3/GSK3) is 
active (Zw3a/GSK3a). This leads to the phosphorylation of ARM/p-catenin, possibly 
by Zw3/GSK3, destablizing cytoplasmic ARM/p-catenin. Association with the 
APC-Zw3/GSK3 complex makes ARM/p-catenin liable to degradation by the 
ubiquit in-proteasome pathway (for review sees Willert and Nusse, 1998). At the 
same time, T-cell factor (TCF) is bound to its DNA-binding recognition site in the 
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nucleus where it represses the expression of target Wnt genes such as c-myc (He et 
cd,, 1998) and c-jun (Mann et al., 1999) in human colon cancer. When a Wnt signal 
protein binds to a receptor of the Frizzled family on the cell surface, the effect of the 
Wnt signal gets relayed to the cytoplasm where Dsh becomes activated (Dsha) 
(Siegfried et al., 1992; Noordermeer et al., 1994; Siegfried et al., 1994), leading to 
the inactivation of Zw3/GSK3 by an unknown mechanism. Inactive Zw3/GSK3 
(Zw3i/GSK3i) fails to phosphorylate ARM/p-catenin that consequently becomes no 
longer susceptible to degradation by the ubiquitin—proteasome pathway. 
ARM/p-catenin, therefore, accumulates in the cytoplasm (van Leeuwen et al., 1994) 
and enters the nucleus by a yet to known mechanism (for review sees Willert and 
Nusse, 1998). Once inside the nucleus, ARM/p-catenin forms a heterodimer with a 
TCF DNA-binding protein, becoming a transcription factor. This complex then 
activates transcription of the downstream Wnt-responsive genes by alleviating the 
repressive effect of TCF (for review sees Willert and Nusse, 1998). Working not 
only as a key mediator of Wnt signal transduction, p-catenin also interacts with APC 
in cytoplasm. Wnt (or APC/p-catenin) signaling pathway has been implicated in a 
couple of carcinomas, including colorectal carcinoma (Hao et al., 2002), endometrial 
carcinoma (Moreno-Bueno et al” 2002) and pancreatic acinar cell carcinoma 
(Abraham et al., 2002). For more information, a comprehensive and regularly 
updated list of Wnt genes and research highlights of the Wnt signaling pathway can 
be viewed at http://www.stanford.edii/�rnusse/wntwindow.html which is hosted by 
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Professor Roel Russe, Howard Hughes Medical Institute, Department of 
Developmental Biology, Beckman Center, Stanford University Medical Center. 
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Figure 4.2. Two-state model of Wnt signaling pathway based on that from 
http://www.stanford.edii/~musse/pathways/celldouble.htmL 
(A) Inactivated state. (B) Activated state. Upon activation by a Wnt 
signal, P-catenin translocates from cytoplasm into nucleus where it 
activates the transcription of target Wnt-responsive gene. 
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4.4. Potential roles of hNP220 in the regulation of chromosome stability and 
oncogenesis 
Our studies show that MAPREl protein is a potential interaction partner of hNP220s. 
Because there is no evidence pointing to the subcellular localization and timing of 
their interaction, and taking into account that hNP220 localizes to nucleus in 
interphase and to cytoplasm diffusedly in mitosis (Inagaki et al., 1996) and that 
MAPREl localizes to cytoplasmic microtubules in interphase and to mitotic spindle 
apparatus in mitosis (Berrueta et al., 1998), we hypothesize that the 
hNP2208-MAPRE 1 interaction occurs presumably in the mitotic spindle apparatus 
that becomes diffusedly interspersed in cytoplasm during mitosis. As mentioned in 
Section 4.2.1, since the yeast homologues of MAPREl, namely Mal3 and Bimlp, 
have long been found to be important in microtubule dynamics, cytokinesis 
checkpoint, mitotic spindle positioning and segregation of episomes (Su and Qi, 
2001), it has been reported that MAPREl is involved in chromosome stability and 
segregation once in the nucleus (for review sees Tirnauer and Bierer, 2000). 
Consequently, the revelation of the hNP220s-MAPRE 1 interaction suggests that 
hNP220 may be involved in the regulation of chromosome stability. The ability to 
regulate chromosome stability may be important to the proposed functions of 
hNP220 in the control of gene expression on the transcriptional and 
post-transcriptional levels by affecting chromosome topology. 
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Another important aspect of the hNP220s-MAPRE 1 interaction may be the inference 
that hNP220 exerts its biological functions in concert with or under the control of 
Wnt signaling pathway. As currently understood, hNP220 has two interacting protein 
partners: FHL2 and MAPREl. FHL2 has been shown to regulate the transcription of 
Wnt-responsive genes via controlling the level of P-catenin (Martin et al., 2002; Wei 
et al., 2003). Meanwhile, MAPREl binds to APC which is a key relay component of 
the Wnt signaling pathway. Taken together, these findings suggest that hNP220 is 
likely to be working in concert with or under the control of Wnt signals. Linkage to 
the Wnt signaling pathway is pronounced as this pathway has been implicated in 
oncogenesis and a large body of work has shown that its molecular abnormalities 
have been found in a couple of carcinomas, including colorectal carcinoma (Hao et 
al,, 2002), endometrial carcinoma (Moreno-Bueno et al., 2002) and pancreatic acinar 
cell carcinoma (Abraham et al., 2002). Association with the Wnt signaling cascade 
suggests hNP220 may be involved in oncogenesis. This speculation is further 
supported by three pieces of evidence. Firstly, the hNP220s-MAPREl interaction 
was identified in this study by screening a CytoTrap® XR HeLa Cell cDNA Library 
which is derived from human cervical epithelial adenocarcinoma. Secondly, FHL2, 
an interaction partner of hNP220, was long thought to be a potential tumor 
suppressor and was shown to be down-regulated in rhabdomyosarcoma (Genini et al., 
1997). Thirdly, MAPREl, a potential interaction partner of hNP220s, interacts with 
APC and this interaction has been suggested to have a role in accelerating events 
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once tumorigenesis of colon has been initiated (for review sees Tirnauer and Bierer, 
2000). These findings make it plausible that hNP220 is closely related to cell 
development, particularly oncogenesis. Based on the hNP220-FHL2 and 
hNP2208-MAPRE 1 interactions, and our previous speculation that hNP220 is a 
mammalian transcription factor because of its transcriptional activating AR domain 
and the ability to bind to both DNA and RNA, we hypothesize that hNP220 is a 
mammalian transcription factor involved in the regulation of tissue-specific 
transcription of proto-oncogenic or oncogenic proteins yet to be found. This 
regulation may occur in response to heart- and skeletal muscle-specific 
transcriptional coactivator FHL2 in concert with or under the control of the Wnt 
signaling pathway. 
It also merits attention the close relationship between chromosome stability and 
oncogenesis. Since chromosomal instability (CIN) is a defining characteristic of most 
human cancers (Nowak et al., 2002), our newly proposed function of hNP220 in the 
regulation of chromosome stability deduced from the hNP220s-MAPREl interaction 
may give us clues and shed light on the potential mechanism(s) through which 
hNP220 exerts its effect on oncogenesis. 
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4.5. Summary 
In this work, we have isolated and characterized the third splice variant of hNP220 
gene, designated hNP220s. The cDNA of hNP220s has a predicted ORF containing 
1139 amino acids. Domain structure of hNP220s resembles that of hNP220a, except 
for the deletion of DNA-binding, AR and MH3 domains and the introduction of a 
40-amino acid long C-terminal leucine-rich basic leucine-zipper like motif (bZLM) 
as the result of a frameshift and a premature stop codon. The introduced bZLM is 
thought to be RNA-binding. Domain organization suggests that hNP220s is 
RNA-binding only and we, therefore, hypothesize that there may be a dual nucleic 
acid binding property among the isoforms of hNP220: DNA+RNA for hNP220a and 
hNP2205, and RNA-only for hNP220s. This duality may be important in the 
previously proposed functions of hNP220 in the packaging, splicing and retention of 
RNA. As revealed by RT-PCR and Northern hybridization, the mRNA transcripts of 
hNP220a and hNP220s are ubiquitously expressed in an array of human fetal and 
adult tissues examined. Due to the identical domain organization of hNP220s to the 
N-terminal of hNP220a, biological functions exhibited in hNP220s are supposedly 
present in hNP220a (hNP220) as well. 
Our yeast two-hybrid CytoTrap® XR HeLa Cell cDNA Library screening unveils the 
potential protein-protein interaction between hNP220s and MAPREl, presumably in 
the mitotic spindle apparatus during mitosis. Their interaction suggests the possible 
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role of hNP220 in the regulation of chromosome stability. Taking into account the 
hNP2208-MAPREl and hNP220-FHL2 interactions, we hypothesize that hNP220 is 
a mammalian transcription factor involved in the regulation of tissue-specific 
transcription of proto-oncogenic or oncogenic proteins yet to be found. Such 
regulation may take place in response to heart- and skeletal muscle-specific 
transcriptional coactivator FHL2 in concert with or under the control of the Wnt 
signaling pathway. Proposed function in the regulation of chromosome stability also 
raises the possibility that hNP220 may be involved in oncogenesis by affecting 
chromosome stability apart from being in concert with or under the control of Wnt 
signals. 
4.6. Concluding questions 
hNP220 is, in essence, implicated in functions as diverse as RNA packaging, splicing 
and retention, myogenesis regulation, transcription control, chromosome stability 
maintenance and oncogenesis. Usually, only a signal transduction pathway can have 
such a diverse functionality. The linkage among the proposed roles of hNP220 is 
intricate and may look apparently unrelated to each other. We believe it is still a long 
way off before having a complete understanding of hNP220 protein. However, the 
work we described here does facilitate future studies substantially. Also, our findings 
raise an interesting question about the underlying mechanism(s) through which 
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hNP220 exerts its function, presumably in oncogenesis. More work has to be done 
and studies to attack all unanswered questions are keenly awaited. 
4.7. Future work 
The characterization of hNP220 has been commenced. While our studies unveil the 
existence of the third splice variant of the hNP220 gene and the potential 
protein-protein interaction between hNP220s and MAPREl, questions remain. First 
of all, in order to ensure that hNP220s encodes for a new isoform of hNP220s, 
detection of hNP220s using antibody specific to its newly introduced bZLM at the 
C-terminal should be employed. 
In the meanwhile, validation of the hNP220s/MAPRE 1 interaction should be 
furthered by co-immunoprecipitation assay in an effort to examine their ability to 
interact with each other under in vitro condition; by fluorescence resonance energy 
transfer (FRET) assay in an attempt to show that the inter-molecular distance 
between them is close enough to allow energy transfer under in vivo condition, 
making the interaction energetically feasible. Following verification, deletion 
mapping could be done to locate the domains of hNP220s and MAPREl that are 
necessary for the interaction. 
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Additionally, work on the better understanding of the involvement of hNP220 in 
microtubule function and Wnt signaling pathway could be done. Options include 
knock-out of the expression of the hNP220 gene by post-transcriptional gene 
silencing such as RNA interference, followed by monitoring of the expression levels 
of genes related to the organization, assembly or dynamics of microtubule and the 
Wnt signaling pathway. Demonstration of any morphological changes of cells, 
including mobility and dynamics of microtubule, upon hNP220s/MAPRE 1 
interaction might be considered as well. 
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Appendix I Cloning vector pEGFP-Cl (reproduced from BD Biosciences 
Clontech, CA, http://www.clontech.com) 
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Appendix II Cloning vector pMyr (reproduced from Stratagene, CA, 
http://www.stratagene.com) 
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Appendix III Cloning vector pSos (reproduced from Stratagene, CA, 
http://www. stratagene. com) 
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